{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:48:50Z","timestamp":1791676130649,"version":"4.3.4"},"reference-count":282,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274233"],"award-info":[{"award-number":["82274233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240146"],"award-info":[{"award-number":["BK20240146"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["22KJA360007"],"award-info":[{"award-number":["22KJA360007"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan Key Project","award":["ZD202403"],"award-info":[{"award-number":["ZD202403"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cerebral cavernous malformations (CCMs) are cerebrovascular diseases characterized by vascular lesions of the central nervous system (CNS) that can result in epileptic seizures, headaches, focal neurologic deficits (FNDs), and hemorrhagic stroke. Germline and somatic loss-of-function (LOF) mutations in one of the three established CCM-associated genes, namely\n                    <jats:italic>CCM1<\/jats:italic>\n                    (or krev interaction trapped protein 1,\n                    <jats:italic>KRIT1<\/jats:italic>\n                    ),\n                    <jats:italic>CCM2<\/jats:italic>\n                    , and\n                    <jats:italic>CCM3<\/jats:italic>\n                    (or programmed cell death 10,\n                    <jats:italic>PDCD10<\/jats:italic>\n                    ), which have been validated as core drivers of CCM pathogenesis and progression. Over the past few decades, a substantially improved understanding of the hallmarks and molecular basis of CCMs has been achieved. Key pathological hallmarks include but are not limited to excessive angiogenesis, vascular leakage, endothelial-mesenchymal transition (EndMT), defective autophagy, inflammation and immune response, oxidative stress, influenced gut microbiome and altered brain vascular microenvironment. These hallmarks are orchestrated by dysregulated signaling cascades, notably MEKK3-KLF2\/4, PI3K-mTOR, and RhoA-ROCK, which integrate genetic, inflammatory, and hemodynamic cues. Concurrently, sophisticated neuroimaging (MRI with SWI\/QSM) and genetic testing now enable precise diagnosis and risk stratification. Although surgical resection remains the mainstay for accessible symptomatic lesions, a wave of mechanism\u2011based pharmacological candidates has shown promising efficacy in preclinical models, and several have advanced to early\u2011phase clinical trials. This review summarizes the current understanding of CCM epidemiology, molecular pathogenesis, diagnosis and therapy, highlighting how the evolving multi\u2011hit concept and the dissection of downstream signaling are paving the way towards personalized management of this complicated vascular disease.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00619-w","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:09:11Z","timestamp":1791662951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebral cavernous malformations: epidemiology, molecular pathogenesis, diagnosis and therapy"],"prefix":"10.1186","volume":"7","author":[{"given":"Suyun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"9","key":"619_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/jmg.2006.041079","volume":"43","author":"N Revencu","year":"2006","unstructured":"Revencu N, Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet. 2006;43(9):716\u201321. https:\/\/doi.org\/10.1136\/jmg.2006.041079.","journal-title":"J Med Genet"},{"key":"619_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-444-63640-9.00021-7","volume":"143","author":"C Ene","year":"2017","unstructured":"Ene C, Kaul A, Kim L. Natural history of cerebral cavernous malformations. Handb Clin Neurol. 2017;143:227\u201332. https:\/\/doi.org\/10.1016\/B978-0-444-63640-9.00021-7.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"619_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ejhg.2011.155","volume":"20","author":"RA Haasdijk","year":"2012","unstructured":"Haasdijk RA, Cheng C, Maat-Kievit AJ, Duckers HJ. Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management. Eur J Hum Genet. 2012;20(2):134\u201340. https:\/\/doi.org\/10.1038\/ejhg.2011.155.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"619_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1474-4422(12)70004-2","volume":"11","author":"R Al-Shahi Salman","year":"2012","unstructured":"Al-Shahi Salman R, Hall JM, Horne MA, Moultrie F, Josephson CB, Bhattacharya JJ, et al. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol. 2012;11(3):217\u201324. https:\/\/doi.org\/10.1016\/S1474-4422(12)70004-2.","journal-title":"Lancet Neurol"},{"issue":"1","key":"619_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCRESAHA.121.318174","volume":"129","author":"DA Snellings","year":"2021","unstructured":"Snellings DA, Hong CC, Ren AA, Lopez-Ramirez MA, Girard R, Srinath A, et al. Cerebral cavernous malformation: from mechanism to therapy. Circ Res. 2021;129(1):195\u2013215. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318174.","journal-title":"Circ Res"},{"issue":"2","key":"619_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3171\/2011.11.PEDS11390","volume":"9","author":"WN Al-Holou","year":"2012","unstructured":"Al-Holou WN, O\u2019Lynnger TM, Pandey AS, Gemmete JJ, Thompson BG, Muraszko KM, et al. Natural history and imaging prevalence of cavernous malformations in children and young adults. J Neurosurg Pediatr. 2012;9(2):198\u2013205. https:\/\/doi.org\/10.3171\/2011.11.PEDS11390.","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"619_CR7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1742-4658.2009.07535.x","volume":"277","author":"F Riant","year":"2010","unstructured":"Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 2010;277(5):1070\u20135. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07535.x.","journal-title":"FEBS J"},{"issue":"5","key":"619_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/neuros\/nyx091","volume":"80","author":"A Akers","year":"2017","unstructured":"Akers A, Al-Shahi Salman R, Awad IA, Dahlem K, Flemming K, Hart B, et al. Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery. 2017;80(5):665\u201380. https:\/\/doi.org\/10.1093\/neuros\/nyx091.","journal-title":"Neurosurgery"},{"issue":"4","key":"619_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1001\/jamaneurol.2018.3634","volume":"76","author":"MO Chohan","year":"2019","unstructured":"Chohan MO, Marchi\u00f2 S, Morrison LA, Sidman RL, Cavenee WK, Dejana E, et al. Emerging pharmacologic targets in cerebral cavernous malformation and potential strategies to alter the natural history of a difficult disease: a review. JAMA Neurol. 2019;76(4):492\u2013500. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3634.","journal-title":"JAMA Neurol"},{"issue":"6","key":"619_CR10","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/380314","volume":"73","author":"CL Liquori","year":"2003","unstructured":"Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet. 2003;73(6):1459\u201364. https:\/\/doi.org\/10.1086\/380314.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"619_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/426952","volume":"76","author":"F Bergametti","year":"2005","unstructured":"Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005;76(1):42\u201351. https:\/\/doi.org\/10.1086\/426952.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"619_CR12","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.20110571","volume":"208","author":"G Boulday","year":"2011","unstructured":"Boulday G, Rudini N, Maddaluno L, Bl\u00e9con A, Arnould M, Gaudric A, et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med. 2011;208(9):1835\u201347. https:\/\/doi.org\/10.1084\/jem.20110571.","journal-title":"J Exp Med"},{"issue":"12","key":"619_CR13","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/hmg\/8.12.2325","volume":"8","author":"T Sahoo","year":"1999","unstructured":"Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, et al. Mutations in the gene encoding KRIT1, a Krev-1\/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet. 1999;8(12):2325\u201333. https:\/\/doi.org\/10.1093\/hmg\/8.12.2325.","journal-title":"Hum Mol Genet"},{"issue":"15","key":"619_CR14","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1056\/NEJM199604113341503","volume":"334","author":"M Gunel","year":"1996","unstructured":"Gunel M, Awad IA, Finberg K, Anson JA, Steinberg GK, Batjer HH, et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996;334(15):946\u201351. https:\/\/doi.org\/10.1056\/NEJM199604113341503.","journal-title":"N Engl J Med"},{"issue":"5","key":"619_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ejmg.2009.05.002","volume":"52","author":"M Cau","year":"2009","unstructured":"Cau M, Loi M, Melis M, Congiu R, Loi A, Meloni C, et al. C329X in KRIT1 is a founder mutation among CCM patients in Sardinia. Eur J Med Genet. 2009;52(5):344\u20138. https:\/\/doi.org\/10.1016\/j.ejmg.2009.05.002.","journal-title":"Eur J Med Genet"},{"issue":"5","key":"619_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.20947","volume":"60","author":"C Denier","year":"2006","unstructured":"Denier C, Labauge P, Bergametti F, Marchelli F, Riant F, Arnoult M, et al. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol. 2006;60(5):550\u20136. https:\/\/doi.org\/10.1002\/ana.20947.","journal-title":"Ann Neurol"},{"issue":"4","key":"619_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000350042","volume":"4","author":"F Riant","year":"2013","unstructured":"Riant F, Bergametti F, Fournier HD, Chapon F, Michalak-Provost S, Cecillon M, et al. CCM3 mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas. Mol Syndromol. 2013;4(4):165\u201372. https:\/\/doi.org\/10.1159\/000350042.","journal-title":"Mol Syndromol"},{"issue":"2","key":"619_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/mgg3.60","volume":"2","author":"S Spiegler","year":"2014","unstructured":"Spiegler S, Najm J, Liu J, Gkalympoudis S, Schr\u00f6der W, Borck G, et al. High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors. Mol Genet Genomic Med. 2014;2(2):176\u201385. https:\/\/doi.org\/10.1002\/mgg3.60.","journal-title":"Mol Genet Genomic Med"},{"issue":"7","key":"619_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1242\/jcs.059329","volume":"123","author":"MG Lampugnani","year":"2010","unstructured":"Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, et al. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci. 2010;123(7):1073\u201380. https:\/\/doi.org\/10.1242\/jcs.059329.","journal-title":"J Cell Sci"},{"issue":"2","key":"619_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/svn-2018-000195","volume":"4","author":"K Wang","year":"2019","unstructured":"Wang K, Zhou HJ, Wang M. CCM3 and cerebral cavernous malformation disease. Stroke Vasc Neurol. 2019;4(2):67\u201370. https:\/\/doi.org\/10.1136\/svn-2018-000195.","journal-title":"Stroke Vasc Neurol"},{"issue":"3","key":"619_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2014.97","volume":"17","author":"R Shenkar","year":"2015","unstructured":"Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG, et al. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015;17(3):188\u201396. https:\/\/doi.org\/10.1038\/gim.2014.97.","journal-title":"Genet Med"},{"issue":"520","key":"619_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw3521","volume":"11","author":"AT Tang","year":"2019","unstructured":"Tang AT, Sullivan KR, Hong CC, Goddard LM, Mahadevan A, Ren A, et al. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. Sci Transl Med. 2019;11(520):eaaw3521. https:\/\/doi.org\/10.1126\/scitranslmed.aaw3521.","journal-title":"Sci Transl Med"},{"issue":"2","key":"619_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/hmg\/ddq433","volume":"20","author":"DA McDonald","year":"2011","unstructured":"McDonald DA, Shenkar R, Shi C, Stockton RA, Akers AL, Kucherlapati MH, et al. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet. 2011;20(2):211\u201322. https:\/\/doi.org\/10.1093\/hmg\/ddq433.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"619_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet. 2009;18(5):919\u201330. https:\/\/doi.org\/10.1093\/hmg\/ddn430.","journal-title":"Hum Mol Genet"},{"issue":"7862","key":"619_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren AA, Snellings DA, Su YS, Hong CC, Castro M, Tang AT, et al. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature. 2021;594(7862):271\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03562-8.","journal-title":"Nature"},{"issue":"5","key":"619_CR26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2021.04.005","volume":"108","author":"J Weng","year":"2021","unstructured":"Weng J, Yang Y, Song D, Huo R, Li H, Chen Y, et al. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. Am J Hum Genet. 2021;108(5):942\u201350. https:\/\/doi.org\/10.1016\/j.ajhg.2021.04.005.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"619_CR27","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1093\/brain\/awad104","volume":"146","author":"J Ren","year":"2023","unstructured":"Ren J, Huang Y, Ren Y, Tu T, Qiu B, Ai D, et al. Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations. Brain. 2023;146(9):3634\u201347. https:\/\/doi.org\/10.1093\/brain\/awad104.","journal-title":"Brain"},{"issue":"3","key":"619_CR28","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2010.5.FOCUS10120","volume":"29","author":"PG Campbell","year":"2010","unstructured":"Campbell PG, Jabbour P, Yadla S, Awad IA. Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. Neurosurg Focus. 2010;29(3):E6. https:\/\/doi.org\/10.3171\/2010.5.FOCUS10120.","journal-title":"Neurosurg Focus"},{"issue":"5","key":"619_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/1971400916665376","volume":"29","author":"G Sparacia","year":"2016","unstructured":"Sparacia G, Speciale C, Banco A, Bencivinni F, Midiri M. Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form. Neuroradiol J. 2016;29(5):326\u201335. https:\/\/doi.org\/10.1177\/1971400916665376.","journal-title":"Neuroradiol J"},{"issue":"3","key":"619_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1474-4422(07)70053-4","volume":"6","author":"P Labauge","year":"2007","unstructured":"Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007;6(3):237\u201344. https:\/\/doi.org\/10.1016\/S1474-4422(07)70053-4.","journal-title":"Lancet Neurol"},{"issue":"1","key":"619_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7461\/jcen.2017.19.1.19","volume":"19","author":"D Ding","year":"2017","unstructured":"Ding D, Starke RM, Crowley RW, Liu KC. Surgical approaches for symptomatic cerebral cavernous malformations of the thalamus and brainstem. J Cerebrovasc Endovasc Neurosurg. 2017;19(1):19\u201335. https:\/\/doi.org\/10.7461\/jcen.2017.19.1.19.","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"issue":"1","key":"619_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13063-020-4202-x","volume":"21","author":"S Lanfranconi","year":"2020","unstructured":"Lanfranconi S, Scola E, Bertani GA, Zarino B, Pallini R, d\u2019Alessandris G, et al. Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial. Trials. 2020;21(1):401. https:\/\/doi.org\/10.1186\/s13063-020-4202-x.","journal-title":"Trials"},{"key":"619_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123044","volume":"461","author":"AO Dulamea","year":"2024","unstructured":"Dulamea AO, Lupescu IC. Cerebral cavernous malformations - an overview on genetics, clinical aspects and therapeutic strategies. J Neurol Sci. 2024;461:123044. https:\/\/doi.org\/10.1016\/j.jns.2024.123044.","journal-title":"J Neurol Sci"},{"issue":"1","key":"619_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1227\/neu.0000000000003459","volume":"98","author":"AL Akers","year":"2026","unstructured":"Akers AL, Albanese J, Alcazar-Felix RJ, Al-Shahi Salman R, Awad IA, Connolly ES, et al. Guidelines for the diagnosis and clinical management of cavernous malformations of the brain and spinal cord: consensus recommendations based on a systematic literature review by the alliance to cure cavernous malformation clinical advisory board experts panel. Neurosurgery. 2026;98(1):3\u201322. https:\/\/doi.org\/10.1227\/neu.0000000000003459.","journal-title":"Neurosurgery"},{"issue":"5","key":"619_CR35","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3171\/2014.1.JNS131619","volume":"120","author":"SA Moore","year":"2014","unstructured":"Moore SA, Brown RD Jr, Christianson TJ, Flemming KD. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg. 2014;120(5):1188\u201392. https:\/\/doi.org\/10.3171\/2014.1.JNS131619.","journal-title":"J Neurosurg"},{"issue":"1","key":"619_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/svn-2023-003004","volume":"10","author":"C Li","year":"2025","unstructured":"Li C, Zhuo L, Kang Y, Liu P, Huang W, Li Q, et al. Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China. Stroke Vasc Neurol. 2025;10(1):45\u201354. https:\/\/doi.org\/10.1136\/svn-2023-003004.","journal-title":"Stroke Vasc Neurol"},{"key":"619_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3016","volume":"339","author":"Z Morris","year":"2009","unstructured":"Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016. https:\/\/doi.org\/10.1136\/bmj.b3016.","journal-title":"BMJ"},{"issue":"7","key":"619_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jamaneurol.2017.0439","volume":"74","author":"KD Flemming","year":"2017","unstructured":"Flemming KD, Graff-Radford J, Aakre J, Kantarci K, Lanzino G, Brown RD Jr, et al. Population-based prevalence of cerebral cavernous malformations in older adults: mayo clinic study of aging. JAMA Neurol. 2017;74(7):801\u20135. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0439.","journal-title":"JAMA Neurol"},{"key":"619_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.wneu.2016.03.080","volume":"91","author":"P Dammann","year":"2016","unstructured":"Dammann P, Jabbarli R, Wittek P, Oppong MD, Kneist A, Zhu Y, et al. Solitary sporadic cerebral cavernous malformations: risk factors of first or recurrent symptomatic hemorrhage and associated functional impairment. World Neurosurg. 2016;91:73\u201380. https:\/\/doi.org\/10.1016\/j.wneu.2016.03.080.","journal-title":"World Neurosurg"},{"key":"619_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/B978-0-444-63640-9.00023-0","volume":"143","author":"HE Goldstein","year":"2017","unstructured":"Goldstein HE, Solomon RA. Epidemiology of cavernous malformations. Handb Clin Neurol. 2017;143:241\u20137. https:\/\/doi.org\/10.1016\/B978-0-444-63640-9.00023-0.","journal-title":"Handb Clin Neurol"},{"key":"619_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101072","volume":"46","author":"A Halmela","year":"2024","unstructured":"Halmela A, Saari E, Raitanen J, Koivisto T, Auvinen A, Fr\u00f6sen J. Trends in the incidence of newly diagnosed cerebral cavernous malformations in Finland: a population-based retrospective cohort study. Lancet Reg Health Eur. 2024;46:101072. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101072.","journal-title":"Lancet Reg Health Eur"},{"issue":"21","key":"619_CR42","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1212\/WNL.0000000000002701","volume":"86","author":"S Taslimi","year":"2016","unstructured":"Taslimi S, Modabbernia A, Amin-Hanjani S, Barker FG 2nd, Macdonald RL. Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies. Neurology. 2016;86(21):1984\u201391. https:\/\/doi.org\/10.1212\/WNL.0000000000002701.","journal-title":"Neurology"},{"issue":"7","key":"619_CR43","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3174\/ajnr.A4724","volume":"37","author":"H Tan","year":"2016","unstructured":"Tan H, Zhang L, Mikati AG, Girard R, Khanna O, Fam MD, et al. Quantitative susceptibility mapping in cerebral cavernous malformations: clinical correlations. AJNR Am J Neuroradiol. 2016;37(7):1209\u201315. https:\/\/doi.org\/10.3174\/ajnr.A4724.","journal-title":"AJNR Am J Neuroradiol"},{"key":"619_CR44","doi-asserted-by":"publisher","first-page":"1281412","DOI":"10.3389\/fneur.2023.1281412","volume":"14","author":"J Lin","year":"2023","unstructured":"Lin J, Weng X, Zheng J, Wu S, Bao Q, Peng F, et al. Case report: Thrombolysis in patients with acute ischemic stroke and cerebral cavernous malformation. Front Neurol. 2023;14:1281412. https:\/\/doi.org\/10.3389\/fneur.2023.1281412.","journal-title":"Front Neurol"},{"key":"619_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2025.111289","volume":"137","author":"MA Haider","year":"2025","unstructured":"Haider MA, Azam F, Smith PD, Farid M, Lout E, Anand S, et al. Management, and outcomes of pediatric cerebral cavernous malformations across age groups: a systematic review and meta-analysis of the literature. J Clin Neurosci. 2025;137:111289. https:\/\/doi.org\/10.1016\/j.jocn.2025.111289.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"619_CR46","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000369200","volume":"38","author":"H Choquet","year":"2014","unstructured":"Choquet H, Pawlikowska L, Nelson J, McCulloch CE, Akers A, Baca B, et al. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity. Cerebrovasc Dis. 2014;38(6):433\u201340. https:\/\/doi.org\/10.1159\/000369200.","journal-title":"Cerebrovasc Dis"},{"key":"619_CR47","unstructured":"Choquet H, Pawlikowska L, Lawton MT, Kim H. Genetics of cerebral cavernous malformations: current status and future prospects. J Neurosurg Sci. 2015;59(3):211\u2013220. https:\/\/pubmed.ncbi.nlm.nih.gov\/25900426\/."},{"key":"619_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2016.01.008","volume":"92","author":"H Choquet","year":"2016","unstructured":"Choquet H, Trapani E, Goitre L, Trabalzini L, Akers A, Fontanella M, et al. Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1. Free Radic Biol Med. 2016;92:100\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.01.008.","journal-title":"Free Radic Biol Med"},{"key":"619_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.freeradbiomed.2021.06.021","volume":"172","author":"A Perrelli","year":"2021","unstructured":"Perrelli A, Retta SF. Polymorphisms in genes related to oxidative stress and inflammation: emerging links with the pathogenesis and severity of cerebral cavernous malformation disease. Free Radic Biol Med. 2021;172:403\u201317. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.06.021.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"619_CR50","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1468-3083.2009.03263.x","volume":"23","author":"J Sirvente","year":"2009","unstructured":"Sirvente J, Enjolras O, Wassef M, Tournier-Lasserve E, Labauge P. Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations. J Eur Acad Dermatol Venereol. 2009;23(9):1066\u201372. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03263.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"619_CR51","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12031-013-0053-1","volume":"51","author":"FR Grippaudo","year":"2013","unstructured":"Grippaudo FR, Piane M, Amoroso M, Longo B, Penco S, Chessa L, et al. Cutaneous venous malformations related to KRIT1 mutation: case report and literature review. J Mol Neurosci. 2013;51(2):442\u20135. https:\/\/doi.org\/10.1007\/s12031-013-0053-1.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"619_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001;1(2):157\u201362. https:\/\/doi.org\/10.1038\/35101031.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"619_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/jmedgenet-2019-106182","volume":"57","author":"M Rath","year":"2020","unstructured":"Rath M, Pagenstecher A, Hoischen A, Felbor U. Postzygotic mosaicism in cerebral cavernous malformation. J Med Genet. 2020;57(3):212\u20136. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106182.","journal-title":"J Med Genet"},{"issue":"5","key":"619_CR54","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3171\/2015.1.JNS141452","volume":"122","author":"JK Cutsforth-Gregory","year":"2015","unstructured":"Cutsforth-Gregory JK, Lanzino G, Link MJ, Brown RD Jr, Flemming KD. Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort. J Neurosurg. 2015;122(5):1214\u201322. https:\/\/doi.org\/10.3171\/2015.1.JNS141452.","journal-title":"J Neurosurg"},{"issue":"9","key":"619_CR55","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.molmed.2020.03.003","volume":"26","author":"S Abdelilah-Seyfried","year":"2020","unstructured":"Abdelilah-Seyfried S, Tournier-Lasserve E, Derry WB. Blocking signalopathic events to treat cerebral cavernous malformations. Trends Mol Med. 2020;26(9):874\u201387. https:\/\/doi.org\/10.1016\/j.molmed.2020.03.003.","journal-title":"Trends Mol Med"},{"issue":"Pt B","key":"619_CR56","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biocel.2016.09.011","volume":"81","author":"SF Retta","year":"2016","unstructured":"Retta SF, Glading AJ. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: two sides of the same coin. Int J Biochem Cell Biol. 2016;81(Pt B):254\u201370. https:\/\/doi.org\/10.1016\/j.biocel.2016.09.011.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"619_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000356839","volume":"37","author":"H Choquet","year":"2014","unstructured":"Choquet H, Nelson J, Pawlikowska L, McCulloch CE, Akers A, Baca B, et al. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis. 2014;37(1):57\u201363. https:\/\/doi.org\/10.1159\/000356839.","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"619_CR58","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1227\/NEU.0b013e31825fd0dc","volume":"71","author":"CD Witiw","year":"2012","unstructured":"Witiw CD, Abou-Hamden A, Kulkarni AV, Silvaggio JA, Schneider C, Wallace MC. Cerebral cavernous malformations and pregnancy: hemorrhage risk and influence on obstetrical management. Neurosurgery. 2012;71(3):626\u201331. https:\/\/doi.org\/10.1227\/NEU.0b013e31825fd0dc.","journal-title":"Neurosurgery"},{"issue":"1","key":"619_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40478-025-01940-1","volume":"13","author":"J Ren","year":"2025","unstructured":"Ren J, Wang D, Wang L, Jiang C, Tian A, Cui Z, et al. Clinical, genomic, and histopathologic diversity in cerebral cavernous malformations. Acta Neuropathol Commun. 2025;13(1):23. https:\/\/doi.org\/10.1186\/s40478-025-01940-1.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"619_CR60","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s12975-025-01360-2","volume":"16","author":"H Hongo","year":"2025","unstructured":"Hongo H, Miyawaki S, Takai K, Ono H, Shimizu M, Matsukawa T, et al. Clinical significance of somatic PIK3CA and MAP3K3 mutations in cerebral and spinal cavernous malformations. Transl Stroke Res. 2025;16(6):1966\u201374. https:\/\/doi.org\/10.1007\/s12975-025-01360-2.","journal-title":"Transl Stroke Res"},{"issue":"7597","key":"619_CR61","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling. Nature. 2016;532(7597):122\u20136. https:\/\/doi.org\/10.1038\/nature17178.","journal-title":"Nature"},{"issue":"1","key":"619_CR62","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1038\/s41467-023-42908-w","volume":"14","author":"AK Ressler","year":"2023","unstructured":"Ressler AK, Snellings DA, Girard R, Gallione CJ, Lightle R, Allen AS, et al. Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations. Nat Commun. 2023;14(1):7009. https:\/\/doi.org\/10.1038\/s41467-023-42908-w.","journal-title":"Nat Commun"},{"issue":"1","key":"619_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15252\/emmm.201505433","volume":"8","author":"R Cuttano","year":"2016","unstructured":"Cuttano R, Rudini N, Bravi L, Corada M, Giampietro C, Papa E, et al. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med. 2016;8(1):6\u201324. https:\/\/doi.org\/10.15252\/emmm.201505433.","journal-title":"EMBO Mol Med"},{"issue":"11","key":"619_CR64","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1084\/jem.20171178","volume":"214","author":"MA Lopez-Ramirez","year":"2017","unstructured":"Lopez-Ramirez MA, Fonseca G, Zeineddine HA, Girard R, Moore T, Pham A, et al. Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J Exp Med. 2017;214(11):3331\u201346. https:\/\/doi.org\/10.1084\/jem.20171178.","journal-title":"J Exp Med"},{"issue":"2","key":"619_CR65","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.devcel.2014.12.016","volume":"32","author":"M Renz","year":"2015","unstructured":"Renz M, Otten C, Faurobert E, Rudolph F, Zhu Y, Boulday G, et al. Regulation of \u03b21 integrin-Klf2-mediated angiogenesis by CCM proteins. Dev Cell. 2015;32(2):181\u201390. https:\/\/doi.org\/10.1016\/j.devcel.2014.12.016.","journal-title":"Dev Cell"},{"issue":"7654","key":"619_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature22075","volume":"545","author":"AT Tang","year":"2017","unstructured":"Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N, et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017;545(7654):305\u201310. https:\/\/doi.org\/10.1038\/nature22075.","journal-title":"Nature"},{"issue":"11","key":"619_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.07.013","volume":"1865","author":"J Li","year":"2019","unstructured":"Li J, Zhao Y, Coleman P, Chen J, Ting KK, Choi JP, et al. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways. Biochim Biophys Acta Mol Basis Dis. 2019;1865(11):165519. https:\/\/doi.org\/10.1016\/j.bbadis.2019.07.013.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"19","key":"619_CR68","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1182\/blood.2021013934","volume":"139","author":"Y Yang","year":"2022","unstructured":"Yang Y, Mumau M, Tober J, Zhu Q, Bennett L, Hong C, et al. Endothelial MEKK3-KLF2\/4 signaling integrates inflammatory and hemodynamic signals during definitive hematopoiesis. Blood. 2022;139(19):2942\u201357. https:\/\/doi.org\/10.1182\/blood.2021013934.","journal-title":"Blood"},{"issue":"2","key":"619_CR69","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.devcel.2014.12.009","volume":"32","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Rawnsley DR, Goddard LM, Pan W, Cao XJ, Jakus Z, et al. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. Dev Cell. 2015;32(2):168\u201380. https:\/\/doi.org\/10.1016\/j.devcel.2014.12.009.","journal-title":"Dev Cell"},{"issue":"11","key":"619_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau0731","volume":"4","author":"JP Choi","year":"2018","unstructured":"Choi JP, Wang R, Yang X, Wang X, Wang L, Ting KK, et al. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. Sci Adv. 2018;4(11):eaau0731. https:\/\/doi.org\/10.1126\/sciadv.aau0731.","journal-title":"Sci Adv"},{"issue":"4","key":"619_CR71","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1161\/CIRCRESAHA.123.324015","volume":"135","author":"W Min","year":"2024","unstructured":"Min W, Qin L, Zhang H, L\u00f3pez-Gir\u00e1ldez F, Jiang N, Kim Y, et al. mTORC1 signaling in brain endothelial progenitors contributes to CCM pathogenesis. Circ Res. 2024;135(4):e94\u2013113. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.324015.","journal-title":"Circ Res"},{"issue":"11","key":"619_CR72","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.15252\/emmm.201505316","volume":"7","author":"S Marchi","year":"2015","unstructured":"Marchi S, Corricelli M, Trapani E, Bravi L, Pittaro A, Delle Monache S, et al. Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med. 2015;7(11):1403\u201317. https:\/\/doi.org\/10.15252\/emmm.201505316.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"619_CR73","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017.","journal-title":"Cell"},{"issue":"4","key":"619_CR74","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183\u2013203. https:\/\/doi.org\/10.1038\/s41580-019-0199-y.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"619_CR75","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000507789","volume":"49","author":"KD Flemming","year":"2020","unstructured":"Flemming KD, Kumar S, Brown RD Jr, Singh RJ, Whitehead K, McCreath L, et al. Cavernous malformation hemorrhagic presentation at diagnosis associated with low 25-hydroxy-vitamin D level. Cerebrovasc Dis. 2020;49(2):216\u201322. https:\/\/doi.org\/10.1159\/000507789.","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"619_CR76","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/antiox9040327","volume":"9","author":"HA Kim","year":"2020","unstructured":"Kim HA, Perrelli A, Ragni A, Retta F, De Silva TM, Sobey CG, et al. Vitamin D deficiency and the risk of cerebrovascular disease. Antioxidants (Basel). 2020;9(4):327. https:\/\/doi.org\/10.3390\/antiox9040327.","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"619_CR77","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2217\/bmm.15.118","volume":"10","author":"R Girard","year":"2016","unstructured":"Girard R, Khanna O, Shenkar R, Zhang L, Wu M, Jesselson M, et al. Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med. 2016;10(3):255\u201364. https:\/\/doi.org\/10.2217\/bmm.15.118.","journal-title":"Biomark Med"},{"issue":"20","key":"619_CR78","doi-asserted-by":"publisher","first-page":"13301","DOI":"10.1074\/jbc.C900009200","volume":"284","author":"LES Crose","year":"2009","unstructured":"Crose LES, Hilder TL, Sciaky N, Johnson GL. Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J Biol Chem. 2009;284(20):13301\u20135. https:\/\/doi.org\/10.1074\/jbc.C900009200.","journal-title":"J Biol Chem"},{"issue":"4","key":"619_CR79","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1084\/jem.20091258","volume":"207","author":"RA Stockton","year":"2010","unstructured":"Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010;207(4):881\u201396. https:\/\/doi.org\/10.1084\/jem.20091258.","journal-title":"J Exp Med"},{"issue":"1","key":"619_CR80","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200121","volume":"10","author":"C Ayata","year":"2024","unstructured":"Ayata C, Kim H, Morrison L, Liao JK, Gutierrez J, Lopez-Toledano M, et al. Role of rho-associated kinase in the pathophysiology of cerebral cavernous malformations. Neurol Genet. 2024;10(1):e200121. https:\/\/doi.org\/10.1212\/NXG.0000000000200121.","journal-title":"Neurol Genet"},{"issue":"6","key":"619_CR81","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/NEN.0b013e31821bc40e","volume":"70","author":"H Schneider","year":"2011","unstructured":"Schneider H, Errede M, Ulrich NH, Virgintino D, Frei K, Bertalanffy H. Impairment of tight junctions and glucose transport in endothelial cells of human cerebral cavernous malformations. J Neuropathol Exp Neurol. 2011;70(6):417\u201329. https:\/\/doi.org\/10.1097\/NEN.0b013e31821bc40e.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"619_CR82","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00401-015-1479-z","volume":"130","author":"SM Stamatovic","year":"2015","unstructured":"Stamatovic SM, Sladojevic N, Keep RF, Andjelkovic AV. PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1\/2-cortactin cross-talk. Acta Neuropathol. 2015;130(5):731\u201350. https:\/\/doi.org\/10.1007\/s00401-015-1479-z.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"619_CR83","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awab117","volume":"144","author":"T Hong","year":"2021","unstructured":"Hong T, Xiao X, Ren J, Cui B, Zong Y, Zou J, et al. Somatic MAP3K3 and PIK3CA mutations in sporadic cerebral and spinal cord cavernous malformations. Brain. 2021;144(9):2648\u201358. https:\/\/doi.org\/10.1093\/brain\/awab117.","journal-title":"Brain"},{"key":"619_CR84","doi-asserted-by":"publisher","first-page":"7937","DOI":"10.1038\/ncomms8937","volume":"6","author":"OS Fisher","year":"2015","unstructured":"Fisher OS, Deng H, Liu D, Zhang Y, Wei R, Deng Y, et al. Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex. Nat Commun. 2015;6:7937. https:\/\/doi.org\/10.1038\/ncomms8937.","journal-title":"Nat Commun"},{"issue":"6","key":"619_CR85","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.str.2015.04.003","volume":"23","author":"X Wang","year":"2015","unstructured":"Wang X, Hou Y, Deng K, Zhang Y, Wang DC, Ding J. Structural insights into the molecular recognition between cerebral cavernous malformation 2 and mitogen-activated protein kinase kinase kinase 3. Structure. 2015;23(6):1087\u201396. https:\/\/doi.org\/10.1016\/j.str.2015.04.003.","journal-title":"Structure"},{"issue":"8","key":"619_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160833","volume":"11","author":"JP Choi","year":"2016","unstructured":"Choi JP, Foley M, Zhou Z, Wong WY, Gokoolparsadh N, Arthur JS, et al. Micro-CT imaging reveals Mekk3 heterozygosity prevents cerebral cavernous malformations in Ccm2-deficient mice. PLoS ONE. 2016;11(8):e0160833. https:\/\/doi.org\/10.1371\/journal.pone.0160833.","journal-title":"PLoS ONE"},{"issue":"8","key":"619_CR87","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/brain\/awag017","volume":"149","author":"J Ren","year":"2026","unstructured":"Ren J, Ren Y, Tian A, Cui Z, Wang D, Yu H, et al. Angiogenic switching in cerebral cavernous malformations driven by MAP3K3-PIK3CA synergy. Brain. 2026;149(8):2860\u201375. https:\/\/doi.org\/10.1093\/brain\/awag017.","journal-title":"Brain"},{"issue":"1","key":"619_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1582-4934.2002.tb00307.x","volume":"6","author":"J Lawler","year":"2002","unstructured":"Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med. 2002;6(1):1\u201312. https:\/\/doi.org\/10.1111\/j.1582-4934.2002.tb00307.x.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"619_CR89","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1038\/s41467-018-06177-2","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zheng D, Zhou T, Song H, Hulsurkar M, Su N, et al. Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nat Commun. 2018;9(1):4080. https:\/\/doi.org\/10.1038\/s41467-018-06177-2.","journal-title":"Nat Commun"},{"issue":"22","key":"619_CR90","doi-asserted-by":"publisher","first-page":"12485","DOI":"10.1073\/pnas.171460498","volume":"98","author":"JC Rodriguez-Manzaneque","year":"2001","unstructured":"Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, Iruela-Arispe ML. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A. 2001;98(22):12485\u201390. https:\/\/doi.org\/10.1073\/pnas.171460498.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"619_CR91","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/jid.2008.447","volume":"129","author":"P Velasco","year":"2009","unstructured":"Velasco P, Huegel R, Brasch J, Schr\u00f6der JM, Weichenthal M, Stockfleth E, et al. The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions. J Invest Dermatol. 2009;129(8):2022\u201330. https:\/\/doi.org\/10.1038\/jid.2008.447.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"619_CR92","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1227\/NEU.0b013e318219569f","volume":"69","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Wu Q, Fass M, Xu JF, You C, M\u00fcller O, et al. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations. Neurosurgery. 2011;69(3):722\u201332. https:\/\/doi.org\/10.1227\/NEU.0b013e318219569f.","journal-title":"Neurosurgery"},{"key":"619_CR93","doi-asserted-by":"publisher","unstructured":"He Y, Zhang H, Yu L, Gunel M, Boggon TJ, Chen H, et al. Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal. 2010;3(116):ra26. https:\/\/doi.org\/10.1126\/scisignal.2000722.","DOI":"10.1126\/scisignal.2000722"},{"issue":"13","key":"619_CR94","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139570","volume":"131","author":"MA Lopez-Ramirez","year":"2021","unstructured":"Lopez-Ramirez MA, Lai CC, Soliman SI, Hale P, Pham A, Estrada EJ, et al. Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation. J Clin Invest. 2021;131(13):e139570. https:\/\/doi.org\/10.1172\/JCI139570.","journal-title":"J Clin Invest"},{"issue":"1","key":"619_CR95","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41467-020-20774-0","volume":"12","author":"HJ Zhou","year":"2021","unstructured":"Zhou HJ, Qin L, Jiang Q, Murray KN, Zhang H, Li B, et al. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model. Nat Commun. 2021;12(1):504. https:\/\/doi.org\/10.1038\/s41467-020-20774-0.","journal-title":"Nat Commun"},{"issue":"9","key":"619_CR96","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm.4169","volume":"22","author":"HJ Zhou","year":"2016","unstructured":"Zhou HJ, Qin L, Zhang H, Tang W, Ji W, He Y, et al. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med. 2016;22(9):1033\u201342. https:\/\/doi.org\/10.1038\/nm.4169.","journal-title":"Nat Med"},{"issue":"7292","key":"619_CR97","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/nature08889","volume":"464","author":"S Nicoli","year":"2010","unstructured":"Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature. 2010;464(7292):1196\u2013200. https:\/\/doi.org\/10.1038\/nature08889.","journal-title":"Nature"},{"key":"619_CR98","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.toxlet.2016.04.023","volume":"254","author":"Y Gao","year":"2016","unstructured":"Gao Y, Yin Y, Xing X, Zhao Z, Lu Y, Sun Y, et al. Arsenic-induced anti-angiogenesis via miR-425-5p-regulated CCM3. Toxicol Lett. 2016;254:22\u201331. https:\/\/doi.org\/10.1016\/j.toxlet.2016.04.023.","journal-title":"Toxicol Lett"},{"issue":"4","key":"619_CR99","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1227\/01.NEU.0000298897.38979.07","volume":"61","author":"R Shenkar","year":"2007","unstructured":"Shenkar R, Shi C, Check IJ, Lipton HL, Awad IA. Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations. Neurosurgery. 2007;61(4):693\u2013703. https:\/\/doi.org\/10.1227\/01.NEU.0000298897.38979.07.","journal-title":"Neurosurgery"},{"issue":"Pt 12","key":"619_CR100","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1242\/jcs.124529","volume":"126","author":"E Dejana","year":"2013","unstructured":"Dejana E, Orsenigo F. Endothelial adherens junctions at a glance. J Cell Sci. 2013;126(Pt 12):2545\u20139. https:\/\/doi.org\/10.1242\/jcs.124529.","journal-title":"J Cell Sci"},{"key":"619_CR101","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3389\/fimmu.2017.01847","volume":"8","author":"N Rahimi","year":"2017","unstructured":"Rahimi N. Defenders and challengers of endothelial barrier function. Front Immunol. 2017;8:1847. https:\/\/doi.org\/10.3389\/fimmu.2017.01847.","journal-title":"Front Immunol"},{"issue":"7","key":"619_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073645","volume":"23","author":"JL Wautier","year":"2022","unstructured":"Wautier JL, Wautier MP. Vascular permeability in diseases. Int J Mol Sci. 2022;23(7):3645. https:\/\/doi.org\/10.3390\/ijms23073645.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"619_CR103","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2010.5.FOCUS10121","volume":"29","author":"S Yadla","year":"2010","unstructured":"Yadla S, Jabbour PM, Shenkar R, Shi C, Campbell PG, Awad IA. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus. 2010;29(3):E4. https:\/\/doi.org\/10.3171\/2010.5.FOCUS10121.","journal-title":"Neurosurg Focus"},{"issue":"10","key":"619_CR104","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/jcbfm.2015.98","volume":"35","author":"AG Mikati","year":"2015","unstructured":"Mikati AG, Khanna O, Zhang L, Girard R, Shenkar R, Guo X, et al. Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015;35(10):1632\u20139. https:\/\/doi.org\/10.1038\/jcbfm.2015.98.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"619_CR105","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029322","volume":"10","author":"MG Lampugnani","year":"2018","unstructured":"Lampugnani MG, Dejana E, Giampietro C. Vascular endothelial (VE)-cadherin, endothelial adherens junctions, and vascular disease. Cold Spring Harb Perspect Biol. 2018;10(10):a029322. https:\/\/doi.org\/10.1101\/cshperspect.a029322.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"619_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165956","volume":"1866","author":"C Scimone","year":"2020","unstructured":"Scimone C, Donato L, Alibrandi S, Esposito T, Alafaci C, D\u2019Angelo R, et al. Transcriptome analysis provides new molecular signatures in sporadic Cerebral Cavernous Malformation endothelial cells. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165956. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165956.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"619_CR107","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.201412147","volume":"209","author":"S Tietz","year":"2015","unstructured":"Tietz S, Engelhardt B. Brain barriers: Crosstalk between complex tight junctions and adherens junctions. J Cell Biol. 2015;209(4):493\u2013506. https:\/\/doi.org\/10.1083\/jcb.201412147.","journal-title":"J Cell Biol"},{"issue":"3","key":"619_CR108","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2010.6.FOCUS10125","volume":"29","author":"JK Burkhardt","year":"2010","unstructured":"Burkhardt JK, Schmidt D, Schoenauer R, Brokopp C, Agarkova I, Bozinov O, et al. Upregulation of transmembrane endothelial junction proteins in human cerebral cavernous malformations. Neurosurg Focus. 2010;29(3):E3. https:\/\/doi.org\/10.3171\/2010.6.FOCUS10125.","journal-title":"Neurosurg Focus"},{"issue":"16","key":"619_CR109","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1074\/jbc.C109.097220","volume":"285","author":"AL Borikova","year":"2010","unstructured":"Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S, et al. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem. 2010;285(16):11760\u20134. https:\/\/doi.org\/10.1074\/jbc.C109.097220.","journal-title":"J Biol Chem"},{"issue":"1","key":"619_CR110","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/hsz-2012-0243","volume":"394","author":"BT Richardson","year":"2013","unstructured":"Richardson BT, Dibble CF, Borikova AL, Johnson GL. Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol Chem. 2013;394(1):35\u201342. https:\/\/doi.org\/10.1515\/hsz-2012-0243.","journal-title":"Biol Chem"},{"issue":"5651","key":"619_CR111","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.1090772","volume":"302","author":"HR Wang","year":"2003","unstructured":"Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science. 2003;302(5651):1775\u20139. https:\/\/doi.org\/10.1126\/science.1090772.","journal-title":"Science"},{"issue":"10","key":"619_CR112","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00018-013-1532-9","volume":"71","author":"OS Fisher","year":"2014","unstructured":"Fisher OS, Boggon TJ. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell Mol Life Sci. 2014;71(10):1881\u201392. https:\/\/doi.org\/10.1007\/s00018-013-1532-9.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"619_CR113","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1096\/fj.201700699R","volume":"32","author":"AM Johnson","year":"2018","unstructured":"Johnson AM, Roach JP, Hu A, Stamatovic SM, Zochowski MR, Keep RF, et al. Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure. FASEB J. 2018;32(5):2615\u201329. https:\/\/doi.org\/10.1096\/fj.201700699R.","journal-title":"FASEB J"},{"issue":"4","key":"619_CR114","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10456-024-09945-5","volume":"27","author":"J Yin","year":"2024","unstructured":"Yin J, Maggi L, Wiesner C, Affolter M, Belting HG. Oscillatory contractile forces refine endothelial cell-cell interactions for continuous lumen formation governed by Heg1\/Ccm1. Angiogenesis. 2024;27(4):845\u201360. https:\/\/doi.org\/10.1007\/s10456-024-09945-5.","journal-title":"Angiogenesis"},{"issue":"2","key":"619_CR115","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.200705175","volume":"179","author":"A Glading","year":"2007","unstructured":"Glading A, Han J, Stockton RA, Ginsberg MH. KRIT-1\/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol. 2007;179(2):247\u201354. https:\/\/doi.org\/10.1083\/jcb.200705175.","journal-title":"J Cell Biol"},{"issue":"47","key":"619_CR116","doi-asserted-by":"publisher","first-page":"33054","DOI":"10.1074\/jbc.M114.582304","volume":"289","author":"PV DiStefano","year":"2014","unstructured":"DiStefano PV, Kuebel JM, Sarelius IH, Glading AJ. KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling. J Biol Chem. 2014;289(47):33054\u201365. https:\/\/doi.org\/10.1074\/jbc.M114.582304.","journal-title":"J Biol Chem"},{"issue":"1","key":"619_CR117","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/jcmm.14773","volume":"24","author":"PV DiStefano","year":"2020","unstructured":"DiStefano PV, Glading AJ. VEGF signalling enhances lesion burden in KRIT1 deficient mice. J Cell Mol Med. 2020;24(1):632\u20139. https:\/\/doi.org\/10.1111\/jcmm.14773.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"619_CR118","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1083\/jcb.201303044","volume":"202","author":"E Faurobert","year":"2013","unstructured":"Faurobert E, Rome C, Lisowska J, Manet-Dup\u00e9 S, Boulday G, Malbouyres M, et al. CCM1-ICAP-1 complex controls \u03b21 integrin-dependent endothelial contractility and fibronectin remodeling. J Cell Biol. 2013;202(3):545\u201361. https:\/\/doi.org\/10.1083\/jcb.201303044.","journal-title":"J Cell Biol"},{"issue":"4","key":"619_CR119","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2012.12.005","volume":"49","author":"W Liu","year":"2013","unstructured":"Liu W, Draheim KM, Zhang R, Calderwood DA, Boggon TJ. Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation. Mol Cell. 2013;49(4):719\u201329. https:\/\/doi.org\/10.1016\/j.molcel.2012.12.005.","journal-title":"Mol Cell"},{"issue":"1","key":"619_CR120","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00415-012-6567-6","volume":"260","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Qiu J, Hu J, Wang G. Concepts and hypothesis: integrin cytoplasmic domain-associated protein-1 (ICAP-1) as a potential player in cerebral cavernous malformation. J Neurol. 2013;260(1):10\u20139. https:\/\/doi.org\/10.1007\/s00415-012-6567-6.","journal-title":"J Neurol"},{"issue":"12","key":"619_CR121","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/nm.2252","volume":"16","author":"D Medici","year":"2010","unstructured":"Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010;16(12):1400\u20136. https:\/\/doi.org\/10.1038\/nm.2252.","journal-title":"Nat Med"},{"issue":"9","key":"619_CR122","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","volume":"41","author":"Z Alvandi","year":"2021","unstructured":"Alvandi Z, Bischoff J. Endothelial-mesenchymal transition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2357\u201369. https:\/\/doi.org\/10.1161\/ATVBAHA.121.313788.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"619_CR123","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/MOH.0000000000000338","volume":"24","author":"MG Lampugnani","year":"2017","unstructured":"Lampugnani MG, Malinverno M, Dejana E, Rudini N. Endothelial cell disease: emerging knowledge from cerebral cavernous malformations. Curr Opin Hematol. 2017;24(3):256\u201364. https:\/\/doi.org\/10.1097\/MOH.0000000000000338.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"619_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10707-x","volume":"10","author":"M Malinverno","year":"2019","unstructured":"Malinverno M, Maderna C, Abu Taha A, Corada M, Orsenigo F, Valentino M, et al. Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat Commun. 2019;10(1):2761. https:\/\/doi.org\/10.1038\/s41467-019-10707-x.","journal-title":"Nat Commun"},{"issue":"10","key":"619_CR125","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.118.313970","volume":"123","author":"MR Detter","year":"2018","unstructured":"Detter MR, Snellings DA, Marchuk DA. Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells. Circ Res. 2018;123(10):1143\u201351. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313970.","journal-title":"Circ Res"},{"issue":"7455","key":"619_CR126","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498(7455):492\u20136. https:\/\/doi.org\/10.1038\/nature12207.","journal-title":"Nature"},{"issue":"8","key":"619_CR127","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCRESAHA.117.309930","volume":"121","author":"SI Cunha","year":"2017","unstructured":"Cunha SI, Magnusson PU, Dejana E, Lampugnani MG. Deregulated TGF-\u03b2\/BMP signaling in vascular malformations. Circ Res. 2017;121(8):981\u201399. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309930.","journal-title":"Circ Res"},{"issue":"27","key":"619_CR128","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1073\/pnas.1501352112","volume":"112","author":"L Bravi","year":"2015","unstructured":"Bravi L, Rudini N, Cuttano R, Giampietro C, Maddaluno L, Ferrarini L, et al. Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc Natl Acad Sci U S A. 2015;112(27):8421\u20136. https:\/\/doi.org\/10.1073\/pnas.1501352112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"619_CR129","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jb\/mvx017","volume":"161","author":"HI Suzuki","year":"2017","unstructured":"Suzuki HI, Katsura A, Mihira H, Horie M, Saito A, Miyazono K. Regulation of TGF-\u03b2-mediated endothelial-mesenchymal transition by microRNA-27. J Biochem. 2017;161(5):417\u201320. https:\/\/doi.org\/10.1093\/jb\/mvx017.","journal-title":"J Biochem"},{"issue":"9","key":"619_CR130","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/CIRCULATIONAHA.123.067438","volume":"150","author":"M Valentino","year":"2024","unstructured":"Valentino M, Malinverno M, Maderna C, Pham VC, R\u00f6del CJ, Zanardi F, et al. BMI1 inhibition improves lesion burden in cerebral cavernous malformations. Circulation. 2024;150(9):738\u201341. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067438.","journal-title":"Circulation"},{"issue":"3","key":"619_CR131","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s12276-023-00962-w","volume":"55","author":"J Ren","year":"2023","unstructured":"Ren J, Xiao X, Li R, Lv C, Zhang Y, Wang L, et al. Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations. Exp Mol Med. 2023;55(3):628\u201342. https:\/\/doi.org\/10.1038\/s12276-023-00962-w.","journal-title":"Exp Mol Med"},{"issue":"11","key":"619_CR132","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1038\/s44321-024-00152-9","volume":"16","author":"VC Pham","year":"2024","unstructured":"Pham VC, R\u00f6del CJ, Valentino M, Malinverno M, Paolini A, M\u00fcnch J, et al. Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations. EMBO Mol Med. 2024;16(11):2827\u201355. https:\/\/doi.org\/10.1038\/s44321-024-00152-9.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"619_CR133","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/15548627.2015.1125073","volume":"12","author":"S Marchi","year":"2016","unstructured":"Marchi S, Retta SF, Pinton P. Cellular processes underlying cerebral cavernous malformations: autophagy as another point of view. Autophagy. 2016;12(2):424\u20135. https:\/\/doi.org\/10.1080\/15548627.2015.1125073.","journal-title":"Autophagy"},{"issue":"1","key":"619_CR134","doi-asserted-by":"publisher","DOI":"10.1080\/21675511.2016.1142640","volume":"4","author":"S Marchi","year":"2016","unstructured":"Marchi S, Trapani E, Corricelli M, Goitre L, Pinton P, Retta SF. Beyond multiple mechanisms and a unique drug: defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies. Rare Dis. 2016;4(1):e1142640. https:\/\/doi.org\/10.1080\/21675511.2016.1142640.","journal-title":"Rare Dis"},{"key":"619_CR135","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/978-1-0716-0640-7_30","volume":"2152","author":"S Marchi","year":"2020","unstructured":"Marchi S, Retta SF, Pinton P. Detection of p62\/SQSTM1 aggregates in cellular models of CCM disease by immunofluorescence. Methods Mol Biol. 2020;2152:417\u201326. https:\/\/doi.org\/10.1007\/978-1-0716-0640-7_30.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"619_CR136","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem. 2009;284(12):8023\u201332. https:\/\/doi.org\/10.1074\/jbc.M900301200.","journal-title":"J Biol Chem"},{"issue":"17","key":"619_CR137","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.cub.2014.07.034","volume":"24","author":"VA Codelia","year":"2014","unstructured":"Codelia VA, Sun G, Irvine KD. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr Biol. 2014;24(17):2012\u20137. https:\/\/doi.org\/10.1016\/j.cub.2014.07.034.","journal-title":"Curr Biol"},{"issue":"3","key":"619_CR138","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/nu10030277","volume":"10","author":"R Zhou","year":"2018","unstructured":"Zhou R, Wang M, Huang H, Li W, Hu Y, Wu T. Lower vitamin D status is associated with an increased risk of ischemic stroke: a systematic review and meta-analysis. Nutrients. 2018;10(3):277. https:\/\/doi.org\/10.3390\/nu10030277.","journal-title":"Nutrients"},{"issue":"1","key":"619_CR139","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13578-020-00514-z","volume":"11","author":"K Wang","year":"2021","unstructured":"Wang K, Chen H, Zhou Z, Zhang H, Zhou HJ, Min W. ATPIF1 maintains normal mitochondrial structure which is impaired by CCM3 deficiency in endothelial cells. Cell Biosci. 2021;11(1):11. https:\/\/doi.org\/10.1186\/s13578-020-00514-z.","journal-title":"Cell Biosci"},{"issue":"3","key":"619_CR140","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1089\/ars.2013.5373","volume":"20","author":"K Nakahira","year":"2014","unstructured":"Nakahira K, Cloonan SM, Mizumura K, Choi AM, Ryter SW. Autophagy: a crucial moderator of redox balance, inflammation, and apoptosis in lung disease. Antioxid Redox Signal. 2014;20(3):474\u201394. https:\/\/doi.org\/10.1089\/ars.2013.5373.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"619_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70342","volume":"170","author":"FL Fontes-Dantas","year":"2026","unstructured":"Fontes-Dantas FL, da Fontoura Galv\u00e3o G, Cunha AM, de Sena Murteira Pinheiro P, Morandi V, de Souza JM. Familial cerebral cavernous malformations: pathophysiology, genetics, biomarkers, and treatment perspectives. J Neurochem. 2026;170(1):e70342. https:\/\/doi.org\/10.1111\/jnc.70342.","journal-title":"J Neurochem"},{"issue":"4","key":"619_CR142","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00018-022-04224-2","volume":"79","author":"ACY Yau","year":"2022","unstructured":"Yau ACY, Globisch MA, Onyeogaziri FC, Conze LL, Smith R, Jauhiainen S, et al. Inflammation and neutrophil extracellular traps in cerebral cavernous malformation. Cell Mol Life Sci. 2022;79(4):206. https:\/\/doi.org\/10.1007\/s00018-022-04224-2.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"619_CR143","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.122.321129","volume":"131","author":"CC Lai","year":"2022","unstructured":"Lai CC, Nelsen B, Frias-Anaya E, Gallego-Gutierrez H, Orecchioni M, Herrera V, et al. Neuroinflammation plays a critical role in cerebral cavernous malformation disease. Circ Res. 2022;131(11):909\u201325. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321129.","journal-title":"Circ Res"},{"key":"619_CR144","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61413","volume":"9","author":"F Orsenigo","year":"2020","unstructured":"Orsenigo F, Conze LL, Jauhiainen S, Corada M, Lazzaroni F, Malinverno M, et al. Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution. Elife. 2020;9:e61413. https:\/\/doi.org\/10.7554\/eLife.61413.","journal-title":"Elife"},{"key":"619_CR145","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainresbull.2020.04.003","volume":"160","author":"W Peng","year":"2020","unstructured":"Peng W, Wu X, Feng D, Zhang Y, Chen X, Ma C, et al. Cerebral cavernous malformation 3 relieves subarachnoid hemorrhage-induced neuroinflammation in rats through inhibiting NF-kB signaling pathway. Brain Res Bull. 2020;160:74\u201384. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.04.003.","journal-title":"Brain Res Bull"},{"issue":"1","key":"619_CR146","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-019-0789-0","volume":"7","author":"J Koskim\u00e4ki","year":"2019","unstructured":"Koskim\u00e4ki J, Zhang D, Li Y, Saadat L, Moore T, Lightle R, et al. Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations. Acta Neuropathol Commun. 2019;7(1):132. https:\/\/doi.org\/10.1186\/s40478-019-0789-0.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"619_CR147","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126167","volume":"4","author":"J Koskim\u00e4ki","year":"2019","unstructured":"Koskim\u00e4ki J, Girard R, Li Y, Saadat L, Zeineddine HA, Lightle R, et al. Comprehensive transcriptome analysis of cerebral cavernous malformation across multiple species and genotypes. JCI Insight. 2019;4(3):e126167. https:\/\/doi.org\/10.1172\/jci.insight.126167.","journal-title":"JCI Insight"},{"issue":"12","key":"619_CR148","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s44161-024-00577-y","volume":"3","author":"FC Onyeogaziri","year":"2024","unstructured":"Onyeogaziri FC, Smith R, Arce M, Huang H, Erzar I, Rorsman C, et al. Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation. Nat Cardiovasc Res. 2024;3(12):1549\u201367. https:\/\/doi.org\/10.1038\/s44161-024-00577-y.","journal-title":"Nat Cardiovasc Res"},{"issue":"2","key":"619_CR149","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","volume":"11","author":"C Shi","year":"2016","unstructured":"Shi C, Shenkar R, Zeineddine HA, Girard R, Fam MD, Austin C, et al. B-cell depletion reduces the maturation of cerebral cavernous malformations in murine models. J Neuroimmune Pharmacol. 2016;11(2):369\u201377. https:\/\/doi.org\/10.1007\/s11481-016-9670-0.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"7","key":"619_CR150","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1161\/ATVBAHA.112.251181","volume":"32","author":"Z Lu","year":"2012","unstructured":"Lu Z, Li Y, Jin J, Zhang X, Lopes-Virella MF, Huang Y. Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler Thromb Vasc Biol. 2012;32(7):1696\u2013706. https:\/\/doi.org\/10.1161\/ATVBAHA.112.251181.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"619_CR151","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11886-017-0931-1","volume":"19","author":"KD Flemming","year":"2017","unstructured":"Flemming KD. Clinical management of cavernous malformations. Curr Cardiol Rep. 2017;19(12):122. https:\/\/doi.org\/10.1007\/s11886-017-0931-1.","journal-title":"Curr Cardiol Rep"},{"issue":"19","key":"619_CR152","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3390\/cells14191510","volume":"14","author":"J Rodemerk","year":"2025","unstructured":"Rodemerk J, Engel A, Horstmann JLH, Rauschenbach L, Darkwah Oppong M, Santos AN, et al. Inflammation in cerebral cavernous malformations: differences between malformation related epilepsy vs symptomatic hemorrhage. Cells. 2025;14(19):1510. https:\/\/doi.org\/10.3390\/cells14191510.","journal-title":"Cells"},{"issue":"1","key":"619_CR153","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12975-017-0561-3","volume":"9","author":"R Girard","year":"2018","unstructured":"Girard R, Zeineddine HA, Fam MD, Mayampurath A, Cao Y, Shi C, et al. Plasma biomarkers of inflammation reflect seizures and hemorrhagic activity of cerebral cavernous malformations. Transl Stroke Res. 2018;9(1):34\u201343. https:\/\/doi.org\/10.1007\/s12975-017-0561-3.","journal-title":"Transl Stroke Res"},{"key":"619_CR154","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jocn.2016.12.023","volume":"37","author":"S Noshiro","year":"2017","unstructured":"Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Ohnishi H, Ohtaki S, et al. Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations. J Clin Neurosci. 2017;37:83\u201390. https:\/\/doi.org\/10.1016\/j.jocn.2016.12.023.","journal-title":"J Clin Neurosci"},{"issue":"7","key":"619_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011786","volume":"5","author":"L Goitre","year":"2010","unstructured":"Goitre L, Balzac F, Degani S, Degan P, Marchi S, Pinton P, et al. KRIT1 regulates the homeostasis of intracellular reactive oxygen species. PLoS ONE. 2010;5(7):e11786. https:\/\/doi.org\/10.1371\/journal.pone.0011786.","journal-title":"PLoS ONE"},{"issue":"1","key":"619_CR156","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1038\/s41598-017-08373-4","volume":"7","author":"L Goitre","year":"2017","unstructured":"Goitre L, DiStefano PV, Moglia A, Nobiletti N, Baldini E, Trabalzini L, et al. Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium. Sci Rep. 2017;7(1):8296. https:\/\/doi.org\/10.1038\/s41598-017-08373-4.","journal-title":"Sci Rep"},{"issue":"9","key":"619_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044705","volume":"7","author":"P Guazzi","year":"2012","unstructured":"Guazzi P, Goitre L, Ferro E, Cutano V, Martino C, Trabalzini L, et al. Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1. PLoS ONE. 2012;7(9):e44705. https:\/\/doi.org\/10.1371\/journal.pone.0044705.","journal-title":"PLoS ONE"},{"issue":"100","key":"619_CR158","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2013.11.020","volume":"68","author":"L Goitre","year":"2014","unstructured":"Goitre L, De Luca E, Braggion S, Trapani E, Guglielmotto M, Biasi F, et al. KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun. Free Radic Biol Med. 2014;68(100):134\u201347. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.11.020.","journal-title":"Free Radic Biol Med"},{"key":"619_CR159","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2017.11.014","volume":"115","author":"C Antognelli","year":"2018","unstructured":"Antognelli C, Trapani E, Delle Monache S, Perrelli A, Daga M, Pizzimenti S, et al. KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for cerebral cavernous malformation disease. Free Radic Biol Med. 2018;115:202\u201318. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.11.014.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"619_CR160","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/antiox8010027","volume":"8","author":"L Cianfruglia","year":"2019","unstructured":"Cianfruglia L, Perrelli A, Fornelli C, Magini A, Gorbi S, Salzano AM, et al. KRIT1 loss-of-function associated with cerebral cavernous malformation disease leads to enhanced S-glutathionylation of distinct structural and regulatory proteins. Antioxidants (Basel). 2019;8(1):27. https:\/\/doi.org\/10.3390\/antiox8010027.","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"619_CR161","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41565-025-01870-y","volume":"20","author":"J Jiang","year":"2025","unstructured":"Jiang J, Zheng H, Wang Z, Wang X, Xie Q, Liu X, et al. Intracellular dehydrogenation catalysis leads to reductive stress and immunosuppression. Nat Nanotechnol. 2025;20(4):554\u201362. https:\/\/doi.org\/10.1038\/s41565-025-01870-y.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"619_CR162","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1042\/BJ20150568","volume":"469","author":"M Dodson","year":"2015","unstructured":"Dodson M, Redmann M, Rajasekaran NS, Darley-Usmar V, Zhang J. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Biochem J. 2015;469(3):347\u201355. https:\/\/doi.org\/10.1042\/BJ20150568.","journal-title":"Biochem J"},{"issue":"1","key":"619_CR163","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41467-020-16436-w","volume":"11","author":"SP Polster","year":"2020","unstructured":"Polster SP, Sharma A, Tanes C, Tang AT, Mericko P, Cao Y, et al. Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020;11(1):2659. https:\/\/doi.org\/10.1038\/s41467-020-16436-w.","journal-title":"Nat Commun"},{"issue":"2","key":"619_CR164","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1096\/fj.201800343R","volume":"33","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li Y, Zou J, Polster SP, Lightle R, Moore T, et al. The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation. FASEB J. 2019;33(2):2132\u201343. https:\/\/doi.org\/10.1096\/fj.201800343R.","journal-title":"FASEB J"},{"issue":"2","key":"619_CR165","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/ijms21020675","volume":"21","author":"S Wei","year":"2020","unstructured":"Wei S, Li Y, Polster SP, Weber CR, Awad IA, Shen L. Cerebral cavernous malformation proteins in barrier maintenance and regulation. Int J Mol Sci. 2020;21(2):675. https:\/\/doi.org\/10.3390\/ijms21020675.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"619_CR166","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/s41467-019-09829-z","volume":"10","author":"EM Chapman","year":"2019","unstructured":"Chapman EM, Lant B, Ohashi Y, Yu B, Schertzberg M, Go C, et al. A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis. Nat Commun. 2019;10(1):1791. https:\/\/doi.org\/10.1038\/s41467-019-09829-z.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"619_CR167","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1242\/dmm.003293","volume":"3","author":"AJ Glading","year":"2010","unstructured":"Glading AJ, Ginsberg MH. Rap1 and its effector KRIT1\/CCM1 regulate beta-catenin signaling. Dis Model Mech. 2010;3(1\u20132):73\u201383. https:\/\/doi.org\/10.1242\/dmm.003293.","journal-title":"Dis Model Mech"},{"issue":"3","key":"619_CR168","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","volume":"131","author":"CC Gibson","year":"2015","unstructured":"Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation. 2015;131(3):289\u201399. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010403.","journal-title":"Circulation"},{"issue":"5","key":"619_CR169","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1172\/JCI44393","volume":"121","author":"AC Chan","year":"2011","unstructured":"Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest. 2011;121(5):1871\u201381. https:\/\/doi.org\/10.1172\/JCI44393.","journal-title":"J Clin Invest"},{"key":"619_CR170","unstructured":"Trapani E, Retta SF. Cerebral cavernous malformation (CCM) disease: from monogenic forms to genetic susceptibility factors. J Neurosurg Sci. 2015;59(3):201\u2013209. https:\/\/pubmed.ncbi.nlm.nih.gov\/25896717\/."},{"issue":"23","key":"619_CR171","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1093\/hmg\/ddu342","volume":"23","author":"TM Mleynek","year":"2014","unstructured":"Mleynek TM, Chan AC, Redd M, Gibson CC, Davis CT, Shi DS, et al. Lack of CCM1 induces hypersprouting and impairs response to flow. Hum Mol Genet. 2014;23(23):6223\u201334. https:\/\/doi.org\/10.1093\/hmg\/ddu342.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"619_CR172","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1161\/CIRCRESAHA.119.315076","volume":"125","author":"CJ R\u00f6del","year":"2019","unstructured":"R\u00f6del CJ, Otten C, Donat S, Louren\u00e7o M, Fischer D, Kuropka B, et al. Blood flow suppresses vascular anomalies in a zebrafish model of cerebral cavernous malformations. Circ Res. 2019;125(10):e43\u201354. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315076.","journal-title":"Circ Res"},{"issue":"9","key":"619_CR173","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.mayocp.2019.11.005","volume":"95","author":"KD Flemming","year":"2020","unstructured":"Flemming KD, Lanzino G. Cerebral cavernous malformation: what a practicing clinician should know. Mayo Clin Proc. 2020;95(9):2005\u201320. https:\/\/doi.org\/10.1016\/j.mayocp.2019.11.005.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"619_CR174","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1242\/bio.201410132","volume":"3","author":"Z Macek Jilkova","year":"2014","unstructured":"Macek Jilkova Z, Lisowska J, Manet S, Verdier C, Deplano V, Geindreau C, et al. CCM proteins control endothelial \u03b21 integrin dependent response to shear stress. Biol Open. 2014;3(12):1228\u201335. https:\/\/doi.org\/10.1242\/bio.201410132.","journal-title":"Biol Open"},{"issue":"10","key":"619_CR175","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172843","volume":"134","author":"S Abdelilah-Seyfried","year":"2024","unstructured":"Abdelilah-Seyfried S, Ola R. Shear stress and pathophysiological PI3K involvement in vascular malformations. J Clin Invest. 2024;134(10):e172843. https:\/\/doi.org\/10.1172\/JCI172843.","journal-title":"J Clin Invest"},{"issue":"5","key":"619_CR176","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/STROKEAHA.114.007512","volume":"46","author":"GB Schulz","year":"2015","unstructured":"Schulz GB, Wieland E, W\u00fcstehube-Lausch J, Boulday G, Moll I, Tournier-Lasserve E, et al. Cerebral cavernous malformation-1 protein controls DLL4-Notch3 signaling between the endothelium and pericytes. Stroke. 2015;46(5):1337\u201343. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007512.","journal-title":"Stroke"},{"issue":"5","key":"619_CR177","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3171\/jns.2005.103.5.0903","volume":"103","author":"J Tu","year":"2005","unstructured":"Tu J, Stoodley MA, Morgan MK, Storer KP. Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. J Neurosurg. 2005;103(5):903\u20139. https:\/\/doi.org\/10.3171\/jns.2005.103.5.0903.","journal-title":"J Neurosurg"},{"issue":"3","key":"619_CR178","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041188","volume":"13","author":"W Min","year":"2023","unstructured":"Min W, Zhou JH. Endothelial cell-pericyte interactions in the pathogenesis of cerebral cavernous malformations (CCMs). Cold Spring Harb Perspect Med. 2023;13(3):a041188. https:\/\/doi.org\/10.1101\/cshperspect.a041188.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"619_CR179","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1161\/ATVBAHA.120.314586","volume":"40","author":"K Wang","year":"2020","unstructured":"Wang K, Zhang H, He Y, Jiang Q, Tanaka Y, Park IH, et al. Mural cell-specific deletion of cerebral cavernous malformation 3 in the brain induces cerebral cavernous malformations. Arterioscler Thromb Vasc Biol. 2020;40(9):2171\u201386. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314586.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"619_CR180","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.1012617108","volume":"108","author":"A Louvi","year":"2011","unstructured":"Louvi A, Chen L, Two AM, Zhang H, Min W, G\u00fcnel M. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci U S A. 2011;108(9):3737\u201342. https:\/\/doi.org\/10.1073\/pnas.1012617108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"619_CR181","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1242\/dev.093526","volume":"141","author":"A Louvi","year":"2014","unstructured":"Louvi A, Nishimura S, G\u00fcnel M. Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration. Development. 2014;141(6):1404\u201315. https:\/\/doi.org\/10.1242\/dev.093526.","journal-title":"Development"},{"key":"619_CR182","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/2051-5960-2-71","volume":"2","author":"J Liu","year":"2014","unstructured":"Liu J, Reeves C, Michalak Z, Coppola A, Diehl B, Sisodiya SM, et al. Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies. Acta Neuropathol Commun. 2014;2:71. https:\/\/doi.org\/10.1186\/2051-5960-2-71.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"619_CR183","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3171\/JNS-07\/09\/0495","volume":"107","author":"CH Ferrier","year":"2007","unstructured":"Ferrier CH, Aronica E, Leijten FS, Spliet WG, Boer K, van Rijen PC, et al. Electrocorticography discharge patterns in patients with a cavernous hemangioma and pharmacoresistent epilepsy. J Neurosurg. 2007;107(3):495\u2013503. https:\/\/doi.org\/10.3171\/JNS-07\/09\/0495.","journal-title":"J Neurosurg"},{"issue":"2","key":"619_CR184","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jon.12477","volume":"28","author":"KA Abid","year":"2018","unstructured":"Abid KA, Sobowale OA, Parkes LM, Naish J, Parker GJM, du Plessis D, et al. Assessing inflammation in acute intracerebral hemorrhage with PK11195 PET and dynamic contrast-enhanced MRI. J Neuroimaging. 2018;28(2):158\u201361. https:\/\/doi.org\/10.1111\/jon.12477.","journal-title":"J Neuroimaging"},{"issue":"4","key":"619_CR185","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10456-025-10011-x","volume":"28","author":"W Zheng","year":"2025","unstructured":"Zheng W, Chen L, Ma J, Zuo Y, Yu S, Li J, et al. Single-cell sequencing insights into the transcriptional landscape of cerebral cavernous malformations. Angiogenesis. 2025;28(4):53. https:\/\/doi.org\/10.1007\/s10456-025-10011-x.","journal-title":"Angiogenesis"},{"issue":"4","key":"619_CR186","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.clineuro.2012.06.023","volume":"115","author":"G Tanriover","year":"2013","unstructured":"Tanriover G, Sozen B, Seker A, Kilic T, Gunel M, Demir N. Ultrastructural analysis of vascular features in cerebral cavernous malformations. Clin Neurol Neurosurg. 2013;115(4):438\u201344. https:\/\/doi.org\/10.1016\/j.clineuro.2012.06.023.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"619_CR187","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-005-0994-8","volume":"109","author":"M Abe","year":"2005","unstructured":"Abe M, Fukudome K, Sugita Y, Oishi T, Tabuchi K, Kawano T. Thrombus and encapsulated hematoma in cerebral cavernous malformations. Acta Neuropathol. 2005;109(5):503\u20139. https:\/\/doi.org\/10.1007\/s00401-005-0994-8.","journal-title":"Acta Neuropathol"},{"key":"619_CR188","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/B978-0-444-63640-9.00025-4","volume":"143","author":"EM Cox","year":"2017","unstructured":"Cox EM, Bambakidis NC, Cohen ML. Pathology of cavernous malformations. Handb Clin Neurol. 2017;143:267\u201377. https:\/\/doi.org\/10.1016\/B978-0-444-63640-9.00025-4.","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"619_CR189","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood-2018-06-856062","volume":"133","author":"MA Lopez-Ramirez","year":"2019","unstructured":"Lopez-Ramirez MA, Pham A, Girard R, Wyseure T, Hale P, Yamashita A, et al. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. Blood. 2019;133(3):193\u2013204. https:\/\/doi.org\/10.1182\/blood-2018-06-856062.","journal-title":"Blood"},{"issue":"3","key":"619_CR190","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/blood-2018-11-887539","volume":"133","author":"VL Bautch","year":"2019","unstructured":"Bautch VL. New plugs for CCM bleeds. Blood. 2019;133(3):183\u20134. https:\/\/doi.org\/10.1182\/blood-2018-11-887539.","journal-title":"Blood"},{"issue":"20","key":"619_CR191","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood.2021015350","volume":"140","author":"MA Globisch","year":"2022","unstructured":"Globisch MA, Onyeogaziri FC, Jauhiainen S, Yau ACY, Orsenigo F, Conze LL, et al. Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation. Blood. 2022;140(20):2154\u201369. https:\/\/doi.org\/10.1182\/blood.2021015350.","journal-title":"Blood"},{"issue":"4","key":"619_CR192","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1161\/STROKEAHA.120.029676","volume":"52","author":"J Oldenburg","year":"2021","unstructured":"Oldenburg J, Malinverno M, Globisch MA, Maderna C, Corada M, Orsenigo F, et al. Propranolol reduces the development of lesions and rescues barrier function in cerebral cavernous malformations: a preclinical study. Stroke. 2021;52(4):1418\u201327. https:\/\/doi.org\/10.1161\/STROKEAHA.120.029676.","journal-title":"Stroke"},{"issue":"6","key":"619_CR193","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.stem.2024.04.019","volume":"31","author":"L Dao","year":"2024","unstructured":"Dao L, You Z, Lu L, Xu T, Sarkar AK, Zhu H, et al. Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids. Cell Stem Cell. 2024;31(6):818-833.e11. https:\/\/doi.org\/10.1016\/j.stem.2024.04.019.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"619_CR194","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","volume":"39","author":"R Al-Shahi Salman","year":"2008","unstructured":"Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Stroke. 2008;39(12):3222\u201330. https:\/\/doi.org\/10.1161\/STROKEAHA.108.515544.","journal-title":"Stroke"},{"issue":"11","key":"619_CR195","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3174\/ajnr.A4427","volume":"36","author":"O Nikoubashman","year":"2015","unstructured":"Nikoubashman O, Di Rocco F, Davagnanam I, Mankad K, Zerah M, Wiesmann M. Prospective hemorrhage rates of cerebral cavernous malformations in children and adolescents based on MRI appearance. AJNR Am J Neuroradiol. 2015;36(11):2177\u201383. https:\/\/doi.org\/10.3174\/ajnr.A4427.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"619_CR196","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1055\/s-0044-1779587","volume":"34","author":"MK Demir","year":"2024","unstructured":"Demir MK, K\u0131l\u0131c D, Zorlu E, K\u0131l\u0131c T. Giant intracranial cavernous malformations: a review on magnetic resonance imaging characteristics. Indian J Radiol Imaging. 2024;34(3):511\u201321. https:\/\/doi.org\/10.1055\/s-0044-1779587.","journal-title":"Indian J Radiol Imaging"},{"issue":"4","key":"619_CR197","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/jmri.25831","volume":"47","author":"HA Zeineddine","year":"2018","unstructured":"Zeineddine HA, Girard R, Cao Y, Hobson N, Fam MD, Stadnik A, et al. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage. J Magn Reson Imaging. 2018;47(4):1133\u20138. https:\/\/doi.org\/10.1002\/jmri.25831.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"619_CR198","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1148\/radiol.2018171918","volume":"288","author":"H Sun","year":"2018","unstructured":"Sun H, Klahr AC, Kate M, Gioia LC, Emery DJ, Butcher KS, et al. Quantitative susceptibility mapping for following intracranial hemorrhage. Radiology. 2018;288(3):830\u20139. https:\/\/doi.org\/10.1148\/radiol.2018171918.","journal-title":"Radiology"},{"issue":"1","key":"619_CR199","doi-asserted-by":"publisher","DOI":"10.3171\/foc.2006.21.1.5","volume":"21","author":"SM Nimjee","year":"2006","unstructured":"Nimjee SM, Powers CJ, Bulsara KR. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus. 2006;21(1):e4. https:\/\/doi.org\/10.3171\/foc.2006.21.1.5.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"619_CR200","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/1754-9485.12269","volume":"59","author":"M Golden","year":"2015","unstructured":"Golden M, Saeidi S, Liem B, Marchand E, Morrison L, Hart B. Sensitivity of patients with familial cerebral cavernous malformations to therapeutic radiation. J Med Imaging Radiat Oncol. 2015;59(1):134\u20136. https:\/\/doi.org\/10.1111\/1754-9485.12269.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"619_CR201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.3.JNS181724","volume":"131","author":"IA Awad","year":"2019","unstructured":"Awad IA, Polster SP. Cavernous angiomas: deconstructing a neurosurgical disease. J Neurosurg. 2019;131(1):1\u201313. https:\/\/doi.org\/10.3171\/2019.3.JNS181724.","journal-title":"J Neurosurg"},{"issue":"2","key":"619_CR202","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.surneu.2007.07.067","volume":"71","author":"I Toldo","year":"2009","unstructured":"Toldo I, Drigo P, Mammi I, Marini V, Carollo C. Vertebral and spinal cavernous angiomas associated with familial cerebral cavernous malformation. Surg Neurol. 2009;71(2):167\u201371. https:\/\/doi.org\/10.1016\/j.surneu.2007.07.067.","journal-title":"Surg Neurol"},{"issue":"4","key":"619_CR203","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3171\/2014.6.SPINE13949","volume":"21","author":"JH Badhiwala","year":"2014","unstructured":"Badhiwala JH, Farrokhyar F, Alhazzani W, Yarascavitch B, Aref M, Algird A, et al. Surgical outcomes and natural history of intramedullary spinal cord cavernous malformations: a single-center series and meta-analysis of individual patient data: clinic article. J Neurosurg Spine. 2014;21(4):662\u201376. https:\/\/doi.org\/10.3171\/2014.6.SPINE13949.","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"619_CR204","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3174\/ajnr.A6584","volume":"41","author":"MC Mabray","year":"2020","unstructured":"Mabray MC, Starcevich J, Hallstrom J, Robinson M, Bartlett M, Nelson J, et al. High prevalence of spinal cord cavernous malformations in the familial cerebral cavernous malformations type 1 cohort. AJNR Am J Neuroradiol. 2020;41(6):1126\u201330. https:\/\/doi.org\/10.3174\/ajnr.A6584.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"619_CR205","doi-asserted-by":"publisher","first-page":"11022","DOI":"10.1038\/s41598-024-61851-4","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Jones P, Zhao M. Identifying potential (re)hemorrhage among sporadic cerebral cavernous malformations using machine learning. Sci Rep. 2024;14(1):11022. https:\/\/doi.org\/10.1038\/s41598-024-61851-4.","journal-title":"Sci Rep"},{"issue":"2","key":"619_CR206","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10048-006-0076-7","volume":"8","author":"U Felbor","year":"2007","unstructured":"Felbor U, Gaetzner S, Verlaan DJ, Vijzelaar R, Rouleau GA, Siegel AM. Large germline deletions and duplication in isolated cerebral cavernous malformation patients. Neurogenetics. 2007;8(2):149\u201353. https:\/\/doi.org\/10.1007\/s10048-006-0076-7.","journal-title":"Neurogenetics"},{"issue":"5","key":"619_CR207","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5483\/bmbrep.2016.49.5.036","volume":"49","author":"J Kim","year":"2016","unstructured":"Kim J. Introduction to cerebral cavernous malformation: a brief review. BMB Rep. 2016;49(5):255\u201362. https:\/\/doi.org\/10.5483\/bmbrep.2016.49.5.036.","journal-title":"BMB Rep"},{"issue":"2","key":"619_CR208","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12031-016-0806-8","volume":"60","author":"E Merello","year":"2016","unstructured":"Merello E, Pavanello M, Consales A, Mascelli S, Raso A, Accogli A, et al. Genetic screening of pediatric cavernous malformations. J Mol Neurosci. 2016;60(2):232\u20138. https:\/\/doi.org\/10.1007\/s12031-016-0806-8.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"619_CR209","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000486292","volume":"9","author":"S Spiegler","year":"2018","unstructured":"Spiegler S, Rath M, Paperlein C, Felbor U. Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol Syndromol. 2018;9(2):60\u20139. https:\/\/doi.org\/10.1159\/000486292.","journal-title":"Mol Syndromol"},{"key":"619_CR210","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/459253","volume":"2013","author":"R D'Angelo","year":"2013","unstructured":"D\u2019Angelo R, Alafaci C, Scimone C, Ruggeri A, Salpietro FM, Bramanti P, et al. Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients. Biomed Res Int. 2013;2013:459253. https:\/\/doi.org\/10.1155\/2013\/459253.","journal-title":"Biomed Res Int"},{"key":"619_CR211","doi-asserted-by":"publisher","first-page":"e1162","DOI":"10.1016\/j.wneu.2018.11.008","volume":"122","author":"S Gui","year":"2019","unstructured":"Gui S, Meng G, Xiao X, Wu Z, Zhang J. Surgical management of brainstem cavernous malformation: report of 67 patients. World Neurosurg. 2019;122:e1162\u201371. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.008.","journal-title":"World Neurosurg"},{"key":"619_CR212","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/808314","volume":"2015","author":"N Mouchtouris","year":"2015","unstructured":"Mouchtouris N, Chalouhi N, Chitale A, Starke RM, Tjoumakaris SI, Rosenwasser RH, et al. Management of cerebral cavernous malformations: from diagnosis to treatment. ScientificWorldJournal. 2015;2015:808314. https:\/\/doi.org\/10.1155\/2015\/808314.","journal-title":"ScientificWorldJournal"},{"issue":"4","key":"619_CR213","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00701-013-1621-4","volume":"155","author":"M Poorthuis","year":"2013","unstructured":"Poorthuis M, Samarasekera N, Kontoh K, Stuart I, Cope B, Kitchen N, et al. Comparative studies of the diagnosis and treatment of cerebral cavernous malformations in adults: systematic review. Acta Neurochir (Wien). 2013;155(4):643\u20139. https:\/\/doi.org\/10.1007\/s00701-013-1621-4.","journal-title":"Acta Neurochir (Wien)"},{"issue":"8","key":"619_CR214","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00381-014-2442-3","volume":"30","author":"B Bilginer","year":"2014","unstructured":"Bilginer B, Narin F, Hanalioglu S, Oguz KK, Soylemezoglu F, Akalan N. Cavernous malformations of the central nervous system (CNS) in children: clinico-radiological features and management outcomes of 36 cases. Childs Nerv Syst. 2014;30(8):1355\u201366. https:\/\/doi.org\/10.1007\/s00381-014-2442-3.","journal-title":"Childs Nerv Syst"},{"key":"619_CR215","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-319-02411-0_20","volume":"119","author":"A Pasqualin","year":"2014","unstructured":"Pasqualin A, Meneghelli P, Giammarusti A, Turazzi S. Results of surgery for cavernomas in critical supratentorial areas. Acta Neurochir Suppl. 2014;119:117\u201323. https:\/\/doi.org\/10.1007\/978-3-319-02411-0_20.","journal-title":"Acta Neurochir Suppl"},{"issue":"7","key":"619_CR216","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1586\/14737175.2015.1055323","volume":"15","author":"BA Gross","year":"2015","unstructured":"Gross BA, Du R. Cerebral cavernous malformations: natural history and clinical management. Expert Rev Neurother. 2015;15(7):771\u20137. https:\/\/doi.org\/10.1586\/14737175.2015.1055323.","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"619_CR217","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00701-009-0186-8","volume":"151","author":"R Carrasco","year":"2009","unstructured":"Carrasco R, Pedrosa M, Pascual JM, Navas M, Liberal R, Sola RG. Cavernous angiomas of the lateral ventricles. Acta Neurochir (Wien). 2009;151(2):149\u201354. https:\/\/doi.org\/10.1007\/s00701-009-0186-8.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"619_CR218","doi-asserted-by":"publisher","DOI":"10.3171\/2010.5.FOCUS10129","volume":"29","author":"JK Liu","year":"2010","unstructured":"Liu JK, Lu Y, Raslan AM, Gultekin SH, Delashaw JB Jr. Cavernous malformations of the optic pathway and hypothalamus: analysis of 65 cases in the literature. Neurosurg Focus. 2010;29(3):E17. https:\/\/doi.org\/10.3171\/2010.5.FOCUS10129.","journal-title":"Neurosurg Focus"},{"issue":"2","key":"619_CR219","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3171\/2012.5.JNS112102","volume":"117","author":"J Kivelev","year":"2012","unstructured":"Kivelev J, Koskela E, Set\u00e4l\u00e4 K, Niemel\u00e4 M, Hernesniemi J. Long-term visual outcome after microsurgical removal of occipital lobe cavernomas. J Neurosurg. 2012;117(2):295\u2013301. https:\/\/doi.org\/10.3171\/2012.5.JNS112102.","journal-title":"J Neurosurg"},{"issue":"Suppl 1","key":"619_CR220","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1227\/NEU.0000000000000212","volume":"10","author":"O Choudhri","year":"2014","unstructured":"Choudhri O, Karamchandani J, Gooderham P, Steinberg GK. Flexible omnidirectional carbon dioxide laser as an effective tool for resection of brainstem, supratentorial, and intramedullary cavernous malformations. Neurosurgery. 2014;10(Suppl 1):34\u201345. https:\/\/doi.org\/10.1227\/NEU.0000000000000212.","journal-title":"Neurosurgery"},{"issue":"3","key":"619_CR221","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3171\/2014.11.JNS13680","volume":"122","author":"BC Flores","year":"2015","unstructured":"Flores BC, Whittemore AR, Samson DS, Barnett SL. The utility of preoperative diffusion tensor imaging in the surgical management of brainstem cavernous malformations. J Neurosurg. 2015;122(3):653\u201362. https:\/\/doi.org\/10.3171\/2014.11.JNS13680.","journal-title":"J Neurosurg"},{"issue":"5","key":"619_CR222","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3171\/2015.4.JNS141945","volume":"124","author":"DD Cavalcanti","year":"2016","unstructured":"Cavalcanti DD, Preul MC, Kalani MY, Spetzler RF. Microsurgical anatomy of safe entry zones to the brainstem. J Neurosurg. 2016;124(5):1359\u201376. https:\/\/doi.org\/10.3171\/2015.4.JNS141945.","journal-title":"J Neurosurg"},{"issue":"2","key":"619_CR223","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3171\/2016.10.JNS161179","volume":"128","author":"Y Lin","year":"2018","unstructured":"Lin Y, Lin F, Kang D, Jiao Y, Cao Y, Wang S. Supratentorial cavernous malformations adjacent to the corticospinal tract: surgical outcomes and predictive value of diffusion tensor imaging findings. J Neurosurg. 2018;128(2):541\u201352. https:\/\/doi.org\/10.3171\/2016.10.JNS161179.","journal-title":"J Neurosurg"},{"key":"619_CR224","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000341792","volume":"27","author":"A Niranjan","year":"2013","unstructured":"Niranjan A, Lunsford LD. Stereotactic radiosurgery guidelines for the management of patients with intracranial cavernous malformations. Prog Neurol Surg. 2013;27:166\u201375. https:\/\/doi.org\/10.1159\/000341792.","journal-title":"Prog Neurol Surg"},{"key":"619_CR225","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.wneu.2022.06.052","volume":"166","author":"C Ogasawara","year":"2022","unstructured":"Ogasawara C, Watanabe G, Young K, Kwon R, Conching A, Palmisciano P, et al. Laser interstitial thermal therapy for cerebral cavernous malformations: a systematic review of indications, safety, and outcomes. World Neurosurg. 2022;166:279-287.e1. https:\/\/doi.org\/10.1016\/j.wneu.2022.06.052.","journal-title":"World Neurosurg"},{"issue":"4","key":"619_CR226","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(25)00075-4","volume":"24","author":"RA Salman","year":"2025","unstructured":"Salman RA, Thrippleton MJ. Pharmacological therapy for cerebral cavernous malformations. Lancet Neurol. 2025;24(4):276\u20137. https:\/\/doi.org\/10.1016\/S1474-4422(25)00075-4.","journal-title":"Lancet Neurol"},{"issue":"3","key":"619_CR227","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144893","volume":"131","author":"W Li","year":"2021","unstructured":"Li W, Shenkar R, Detter MR, Moore T, Benavides C, Lightle R, et al. Propranolol inhibits cavernous vascular malformations by \u03b21 adrenergic receptor antagonism in animal models. J Clin Invest. 2021;131(3):e144893. https:\/\/doi.org\/10.1172\/JCI144893.","journal-title":"J Clin Invest"},{"issue":"6","key":"619_CR228","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/cas.13611","volume":"109","author":"L Zhu","year":"2018","unstructured":"Zhu L, Xie J, Liu Z, Huang Z, Huang M, Yin H, et al. Pigment epithelium-derived factor\/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol. Cancer Sci. 2018;109(6):1981\u201394. https:\/\/doi.org\/10.1111\/cas.13611.","journal-title":"Cancer Sci"},{"issue":"1","key":"619_CR229","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1474-4422(22)00409-4","volume":"22","author":"S Lanfranconi","year":"2023","unstructured":"Lanfranconi S, Scola E, Meessen JMTA, Pallini R, Bertani GA, Al-Shahi Salman R, et al. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial. Lancet Neurol. 2023;22(1):35\u201344. https:\/\/doi.org\/10.1016\/S1474-4422(22)00409-4.","journal-title":"Lancet Neurol"},{"issue":"6","key":"619_CR230","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s12975-023-01199-5","volume":"15","author":"S Ikramuddin","year":"2024","unstructured":"Ikramuddin S, Liu S, Ryan D, Hassani S, Hasan D, Feng W. Propranolol or beta-blockers for cerebral cavernous malformation: a systematic review and meta-analysis of literature in both preclinical and clinical studies. Transl Stroke Res. 2024;15(6):1088\u201397. https:\/\/doi.org\/10.1007\/s12975-023-01199-5.","journal-title":"Transl Stroke Res"},{"issue":"5","key":"619_CR231","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1021\/acsptsci.2c00006","volume":"5","author":"MJ Hagan","year":"2022","unstructured":"Hagan MJ, Shenkar R, Srinath A, Romanos SG, Stadnik A, Kahn ML, et al. Rapamycin in cerebral cavernous malformations: what doses to test in mice and humans. ACS Pharmacol Transl Sci. 2022;5(5):266\u201377. https:\/\/doi.org\/10.1021\/acsptsci.2c00006.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"6","key":"619_CR232","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/neuros\/nyy539","volume":"85","author":"SP Polster","year":"2019","unstructured":"Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, et al. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) trial. Neurosurgery. 2019;85(6):843\u201353. https:\/\/doi.org\/10.1093\/neuros\/nyy539.","journal-title":"Neurosurgery"},{"issue":"4","key":"619_CR233","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1474-4422(25)00036-5","volume":"24","author":"IA Awad","year":"2025","unstructured":"Awad IA, Alcazar-Felix RJ, Stadnik A, Kinkade S, Jhaveri A, Lee J, et al. Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1\/2a, randomised placebo-controlled trial. Lancet Neurol. 2025;24(4):295\u2013304. https:\/\/doi.org\/10.1016\/S1474-4422(25)00036-5.","journal-title":"Lancet Neurol"},{"issue":"3","key":"619_CR234","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/STROKEAHA.118.024058","volume":"50","author":"R Shenkar","year":"2019","unstructured":"Shenkar R, Peiper A, Pardo H, Moore T, Lightle R, Girard R, et al. Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10\/Ccm3 disease. Stroke. 2019;50(3):738\u201344. https:\/\/doi.org\/10.1161\/STROKEAHA.118.024058.","journal-title":"Stroke"},{"issue":"1","key":"619_CR235","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/STROKEAHA.116.015013","volume":"48","author":"R Shenkar","year":"2017","unstructured":"Shenkar R, Shi C, Austin C, Moore T, Lightle R, Cao Y, et al. RhoA kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations. Stroke. 2017;48(1):187\u201394. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015013.","journal-title":"Stroke"},{"issue":"3","key":"619_CR236","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12975-019-00737-4","volume":"11","author":"MC Mabray","year":"2020","unstructured":"Mabray MC, Caprihan A, Nelson J, McCulloch CE, Zafar A, Kim H, et al. Effect of simvastatin on permeability in cerebral cavernous malformation type 1 patients: results from a pilot small randomized controlled clinical trial. Transl Stroke Res. 2020;11(3):319\u201321. https:\/\/doi.org\/10.1007\/s12975-019-00737-4.","journal-title":"Transl Stroke Res"},{"issue":"3","key":"619_CR237","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1227\/neu.0000000000002480","volume":"93","author":"LL Marques","year":"2023","unstructured":"Marques LL, Jaeggi C, Branca M, Raabe A, Bervini D, Goldberg J. Bleeding risk of cerebral cavernous malformations in patients on statin and antiplatelet medication: a cohort study. Neurosurgery. 2023;93(3):699\u2013705. https:\/\/doi.org\/10.1227\/neu.0000000000002480.","journal-title":"Neurosurgery"},{"key":"619_CR238","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jocn.2020.04.012","volume":"78","author":"S Gomez-Paz","year":"2020","unstructured":"Gomez-Paz S, Salem MM, Maragkos GA, Ascanio LC, Enriquez-Marulanda A, Lee M, et al. Role of aspirin and statin therapy in patients with cerebral cavernous malformations. J Clin Neurosci. 2020;78:246\u201351. https:\/\/doi.org\/10.1016\/j.jocn.2020.04.012.","journal-title":"J Clin Neurosci"},{"key":"619_CR239","doi-asserted-by":"publisher","first-page":"e767","DOI":"10.1016\/j.wneu.2019.09.161","volume":"133","author":"KD Flemming","year":"2020","unstructured":"Flemming KD, Kumar S, Brown RD Jr, Lanzino G. Predictors of initial presentation with hemorrhage in patients with cavernous malformations. World Neurosurg. 2020;133:e767\u201373. https:\/\/doi.org\/10.1016\/j.wneu.2019.09.161.","journal-title":"World Neurosurg"},{"issue":"12","key":"619_CR240","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1161\/STROKEAHA.112.668533","volume":"43","author":"HM Schneble","year":"2012","unstructured":"Schneble HM, Soumare A, Herv\u00e9 D, Bresson D, Guichard JP, Riant F, et al. Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke. 2012;43(12):3196\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.112.668533.","journal-title":"Stroke"},{"issue":"4","key":"619_CR241","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000321801","volume":"46","author":"D Aguilera","year":"2010","unstructured":"Aguilera D, Tomita T, Goldman S, Fangusaro J. Incidental resolution of a radiation-induced cavernous hemangioma of the brain following the use of bevacizumab in a child with recurrent medulloblastoma. Pediatr Neurosurg. 2010;46(4):303\u20137. https:\/\/doi.org\/10.1159\/000321801.","journal-title":"Pediatr Neurosurg"},{"issue":"2","key":"619_CR242","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/STROKEAHA.111.625467","volume":"43","author":"DA McDonald","year":"2012","unstructured":"McDonald DA, Shi C, Shenkar R, Stockton RA, Liu F, Ginsberg MH, et al. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012;43(2):571\u20134. https:\/\/doi.org\/10.1161\/STROKEAHA.111.625467.","journal-title":"Stroke"},{"issue":"3","key":"619_CR243","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12975-019-00725-8","volume":"11","author":"L McKerracher","year":"2020","unstructured":"McKerracher L, Shenkar R, Abbinanti M, Cao Y, Peiper A, Liao JK, et al. A brain-targeted orally available ROCK2 inhibitor benefits mild and aggressive cavernous angioma disease. Transl Stroke Res. 2020;11(3):365\u201376. https:\/\/doi.org\/10.1007\/s12975-019-00725-8.","journal-title":"Transl Stroke Res"},{"issue":"21","key":"619_CR244","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1073\/pnas.1702942114","volume":"114","author":"S Nishimura","year":"2017","unstructured":"Nishimura S, Mishra-Gorur K, Park J, Surovtseva YV, Sebti SM, Levchenko A, et al. Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proc Natl Acad Sci U S A. 2017;114(21):5503\u20138. https:\/\/doi.org\/10.1073\/pnas.1702942114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"619_CR245","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200907RR","volume":"36","author":"S McCurdy","year":"2022","unstructured":"McCurdy S, Lin J, Shenkar R, Moore T, Lightle R, Faurobert E, et al. \u03b21 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB J. 2022;36(12):e22629. https:\/\/doi.org\/10.1096\/fj.202200907RR.","journal-title":"FASEB J"},{"issue":"6","key":"619_CR246","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000734","volume":"18","author":"J Li","year":"2020","unstructured":"Li J, Zhao Y, Choi J, Ting KK, Coleman P, Chen J, et al. Targeting miR-27a\/VE-cadherin interactions rescues cerebral cavernous malformations in mice. PLoS Biol. 2020;18(6):e3000734. https:\/\/doi.org\/10.1371\/journal.pbio.3000734.","journal-title":"PLoS Biol"},{"issue":"10","key":"619_CR247","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809155","volume":"10","author":"C Otten","year":"2018","unstructured":"Otten C, Knox J, Boulday G, Eymery M, Haniszewski M, Neuenschwander M, et al. Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations. EMBO Mol Med. 2018;10(10):EMMM201809155. https:\/\/doi.org\/10.15252\/emmm.201809155.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"619_CR248","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/STROKEAHA.119.027207","volume":"51","author":"C Cardoso","year":"2020","unstructured":"Cardoso C, Arnould M, De Luca C, Otten C, Abdelilah-Seyfried S, Heredia A, et al. Novel chronic mouse model of cerebral cavernous malformations. Stroke. 2020;51(4):1272\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027207.","journal-title":"Stroke"},{"issue":"11","key":"619_CR249","doi-asserted-by":"publisher","first-page":"15389","DOI":"10.1021\/acsomega.8b01653","volume":"3","author":"E De Luca","year":"2018","unstructured":"De Luca E, Pedone D, Moglianetti M, Pulcini D, Perrelli A, Retta SF, et al. Multifunctional Platinum@BSA-rapamycin nanocarriers for the combinatorial therapy of cerebral cavernous malformation. ACS Omega. 2018;3(11):15389\u201398. https:\/\/doi.org\/10.1021\/acsomega.8b01653.","journal-title":"ACS Omega"},{"issue":"28","key":"619_CR250","doi-asserted-by":"publisher","first-page":"12640","DOI":"10.1073\/pnas.1000132107","volume":"107","author":"J W\u00fcstehube","year":"2010","unstructured":"W\u00fcstehube J, Bartol A, Liebler SS, Br\u00fctsch R, Zhu Y, Felbor U, et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A. 2010;107(28):12640\u20135. https:\/\/doi.org\/10.1073\/pnas.1000132107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"619_CR251","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/jcmm.13105","volume":"21","author":"C You","year":"2017","unstructured":"You C, Zhao K, Dammann P, Keyvani K, Kreitschmann-Andermahr I, Sure U, et al. EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation. J Cell Mol Med. 2017;21(9):1848\u201358. https:\/\/doi.org\/10.1111\/jcmm.13105.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"619_CR252","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/biof.1197","volume":"41","author":"A Moglia","year":"2015","unstructured":"Moglia A, Goitre L, Gianoglio S, Baldini E, Trapani E, Genre A, et al. Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast. BioFactors. 2015;41(1):15\u201327. https:\/\/doi.org\/10.1002\/biof.1197.","journal-title":"BioFactors"},{"issue":"6","key":"619_CR253","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1039\/c5nr08358c","volume":"8","author":"M Moglianetti","year":"2016","unstructured":"Moglianetti M, De Luca E, Pedone D, Marotta R, Catelani T, Sartori B, et al. Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model. Nanoscale. 2016;8(6):3739\u201352. https:\/\/doi.org\/10.1039\/c5nr08358c.","journal-title":"Nanoscale"},{"issue":"11","key":"619_CR254","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/cmdc.201600115","volume":"11","author":"SH Olesen","year":"2016","unstructured":"Olesen SH, Zhu JY, Martin MP, Sch\u00f6nbrunn E. Discovery of diverse small-molecule inhibitors of Mammalian Sterile20-like Kinase 3 (MST3). ChemMedChem. 2016;11(11):1137\u201344. https:\/\/doi.org\/10.1002\/cmdc.201600115.","journal-title":"ChemMedChem"},{"issue":"1","key":"619_CR255","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/NRL.0b013e31813e343f","volume":"14","author":"A Coban","year":"2008","unstructured":"Coban A, Gurses C, Bilgic B, Sencer S, Karasu A, Bebek N, et al. Sporadic multiple cerebral cavernomatosis: report of a case and review of literature. Neurologist. 2008;14(1):46\u20139. https:\/\/doi.org\/10.1097\/NRL.0b013e31813e343f.","journal-title":"Neurologist"},{"issue":"29","key":"619_CR256","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019800","volume":"99","author":"K Ishii","year":"2020","unstructured":"Ishii K, Tozaka N, Tsutsumi S, Muroi A, Tamaoka A. Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: a case report. Medicine (Baltimore). 2020;99(29):e19800. https:\/\/doi.org\/10.1097\/MD.0000000000019800.","journal-title":"Medicine (Baltimore)"},{"key":"619_CR257","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.seizure.2016.11.009","volume":"45","author":"Y Lee","year":"2017","unstructured":"Lee Y, Cho KH, Kim HI, Lee SK, Cho YJ, Heo K, et al. Clinical outcome following medical treatment of cavernous malformation related epilepsy. Seizure. 2017;45:64\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2016.11.009.","journal-title":"Seizure"},{"issue":"8","key":"619_CR258","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1161\/STROKEAHA.121.037009","volume":"53","author":"SM Zuurbier","year":"2022","unstructured":"Zuurbier SM, Hickman CR, Rinkel LA, Berg R, Sure U, Al-Shahi SR. Association between beta-blocker or statin drug use and the risk of hemorrhage from cerebral cavernous malformations. Stroke. 2022;53(8):2521\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037009.","journal-title":"Stroke"},{"issue":"9","key":"619_CR259","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrd3802","volume":"11","author":"DC Rubinsztein","year":"2012","unstructured":"Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 2012;11(9):709\u201330. https:\/\/doi.org\/10.1038\/nrd3802.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"619_CR260","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s12975-024-01270-9","volume":"16","author":"RJ Alcazar-Felix","year":"2025","unstructured":"Alcazar-Felix RJ, Shenkar R, Benavides CR, Bindal A, Srinath A, Li Y, et al. Except for robust outliers, rapamycin increases lesion burden in a murine model of cerebral cavernous malformations. Transl Stroke Res. 2025;16(3):859\u201367. https:\/\/doi.org\/10.1007\/s12975-024-01270-9.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"619_CR261","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12017-018-8484-z","volume":"20","author":"MA Evans","year":"2018","unstructured":"Evans MA, Kim HA, Ling YH, Uong S, Vinh A, De Silva TM, et al. Vitamin D(3) supplementation reduces subsequent brain injury and inflammation associated with ischemic stroke. Neuromol Med. 2018;20(1):147\u201359. https:\/\/doi.org\/10.1007\/s12017-018-8484-z.","journal-title":"Neuromol Med"},{"issue":"3","key":"619_CR262","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3233\/JAD-140411","volume":"42","author":"MF Nissou","year":"2014","unstructured":"Nissou MF, Guttin A, Zenga C, Berger F, Issartel JP, Wion D. Additional clues for a protective role of vitamin D in neurodegenerative diseases: 1,25-dihydroxyvitamin D3 triggers an anti-inflammatory response in brain pericytes. J Alzheimers Dis. 2014;42(3):789\u201399. https:\/\/doi.org\/10.3233\/JAD-140411.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"619_CR263","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/biomedicines11020480","volume":"11","author":"A Perrelli","year":"2023","unstructured":"Perrelli A, Bozza A, Ferraris C, Osella S, Moglia A, Mioletti S, et al. Multidrug-loaded lipid nanoemulsions for the combinatorial treatment of cerebral cavernous malformation disease. Biomedicines. 2023;11(2):480. https:\/\/doi.org\/10.3390\/biomedicines11020480.","journal-title":"Biomedicines"},{"issue":"4","key":"619_CR264","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/biochem5040035","volume":"5","author":"CF Manful","year":"2025","unstructured":"Manful CF, Fordjour E, Ikumoinein E, Abbey L, Thomas R. Therapeutic strategies targeting oxidative stress and inflammation: a narrative review. BioChem. 2025;5(4):35. https:\/\/doi.org\/10.3390\/biochem5040035.","journal-title":"BioChem"},{"issue":"11","key":"619_CR265","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214444","volume":"105","author":"GK Bergey","year":"2025","unstructured":"Bergey GK. Guidance in the medical treatment of recent-onset seizures associated with cerebral cavernous malformations. Neurology. 2025;105(11):e214444. https:\/\/doi.org\/10.1212\/WNL.0000000000214444.","journal-title":"Neurology"},{"issue":"18","key":"619_CR266","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182190f37","volume":"76","author":"CB Josephson","year":"2011","unstructured":"Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi SR. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 2011;76(18):1548\u201354. https:\/\/doi.org\/10.1212\/WNL.0b013e3182190f37.","journal-title":"Neurology"},{"issue":"10","key":"619_CR267","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1474-4422(19)30231-5","volume":"18","author":"SM Zuurbier","year":"2019","unstructured":"Zuurbier SM, Hickman CR, Tolias CS, Rinkel LA, Leyrer R, Flemming KD, et al. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 2019;18(10):935\u201341. https:\/\/doi.org\/10.1016\/S1474-4422(19)30231-5.","journal-title":"Lancet Neurol"},{"key":"619_CR268","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.622547","volume":"8","author":"CD Much","year":"2021","unstructured":"Much CD, Sendtner BS, Schwefel K, Freund E, Bekeschus S, Otto O, et al. Inactivation of cerebral cavernous malformation genes results in accumulation of von willebrand factor and redistribution of weibel-palade bodies in endothelial cells. Front Mol Biosci. 2021;8:622547. https:\/\/doi.org\/10.3389\/fmolb.2021.622547.","journal-title":"Front Mol Biosci"},{"key":"619_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113861","volume":"383","author":"DG Fisher","year":"2025","unstructured":"Fisher DG, Hoch MR, Gorick CM, Huchthausen C, Breza VR, Sharifi KA, et al. Focused ultrasound augments the delivery and penetration of model therapeutics into cerebral cavernous malformations. J Control Release. 2025;383:113861. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113861.","journal-title":"J Control Release"},{"key":"619_CR270","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2377-14-50","volume":"14","author":"G Meng","year":"2014","unstructured":"Meng G, Bai C, Yu T, Wu Z, Liu X, Zhang J, et al. The association between cerebral developmental venous anomaly and concomitant cavernous malformation: an observational study using magnetic resonance imaging. BMC Neurol. 2014;14:50. https:\/\/doi.org\/10.1186\/1471-2377-14-50.","journal-title":"BMC Neurol"},{"issue":"2","key":"619_CR271","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3174\/ajnr.A1822","volume":"31","author":"TA Petersen","year":"2010","unstructured":"Petersen TA, Morrison LA, Schrader RM, Hart BL. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype. AJNR Am J Neuroradiol. 2010;31(2):377\u201382. https:\/\/doi.org\/10.3174\/ajnr.A1822.","journal-title":"AJNR Am J Neuroradiol"},{"key":"619_CR272","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-0640-7_1","volume":"2152","author":"SF Retta","year":"2020","unstructured":"Retta SF, Perrelli A, Trabalzini L, Finetti F. From genes and mechanisms to molecular-targeted therapies: the long climb to the cure of cerebral cavernous malformation (CCM) disease. Methods Mol Biol. 2020;2152:3\u201325. https:\/\/doi.org\/10.1007\/978-1-0716-0640-7_1.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"619_CR273","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrneurol.2009.177","volume":"5","author":"S Batra","year":"2009","unstructured":"Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol. 2009;5(12):659\u201370. https:\/\/doi.org\/10.1038\/nrneurol.2009.177.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"619_CR274","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2011.8.JNS101241","volume":"116","author":"DD Cavalcanti","year":"2012","unstructured":"Cavalcanti DD, Kalani MY, Martirosyan NL, Eales J, Spetzler RF, Preul MC. Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg. 2012;116(1):122\u201332. https:\/\/doi.org\/10.3171\/2011.8.JNS101241.","journal-title":"J Neurosurg"},{"issue":"4","key":"619_CR275","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/01.STR.0000157586.20479.fd","volume":"36","author":"J Gault","year":"2005","unstructured":"Gault J, Shenkar R, Recksiek P, Awad IA. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke. 2005;36(4):872\u20134. https:\/\/doi.org\/10.1161\/01.STR.0000157586.20479.fd.","journal-title":"Stroke"},{"issue":"1","key":"619_CR276","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1074\/mcp.M800266-MCP200","volume":"8","author":"M Goudreault","year":"2009","unstructured":"Goudreault M, D\u2019Ambrosio LM, Kean MJ, Mullin MJ, Larsen BG, Sanchez A, et al. A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol Cell Proteomics. 2009;8(1):157\u201371. https:\/\/doi.org\/10.1074\/mcp.M800266-MCP200.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"619_CR277","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12860-018-0175-y","volume":"19","author":"N Suryavanshi","year":"2018","unstructured":"Suryavanshi N, Furmston J, Ridley AJ. The STRIPAK complex components FAM40A and FAM40B regulate endothelial cell contractility via ROCKs. BMC Cell Biol. 2018;19(1):26. https:\/\/doi.org\/10.1186\/s12860-018-0175-y.","journal-title":"BMC Cell Biol"},{"issue":"12","key":"619_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02899","volume":"5","author":"J Abou-Fadel","year":"2019","unstructured":"Abou-Fadel J, Vasquez M, Grajeda B, Ellis C, Zhang J. Systems-wide analysis unravels the new roles of CCM signal complex (CSC). Heliyon. 2019;5(12):e02899. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02899.","journal-title":"Heliyon"},{"issue":"Pt 4","key":"619_CR279","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1242\/jcs.138388","volume":"127","author":"KM Draheim","year":"2014","unstructured":"Draheim KM, Fisher OS, Boggon TJ, Calderwood DA. Cerebral cavernous malformation proteins at a glance. J Cell Sci. 2014;127(Pt 4):701\u20137. https:\/\/doi.org\/10.1242\/jcs.138388.","journal-title":"J Cell Sci"},{"key":"619_CR280","unstructured":"Fontanella M, Bacigaluppi S. Treatment of cerebral cavernous malformations: where do we stand? J Neurosurg Sci. 2015;59(3):199\u2013200. https:\/\/pubmed.ncbi.nlm.nih.gov\/25971231\/."},{"issue":"5","key":"619_CR281","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S0002-9440(10)63409-8","volume":"165","author":"NW Plummer","year":"2004","unstructured":"Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA. Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am J Pathol. 2004;165(5):1509\u201318. https:\/\/doi.org\/10.1016\/S0002-9440(10)63409-8.","journal-title":"Am J Pathol"},{"issue":"2","key":"619_CR282","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nm.1911","volume":"15","author":"KJ Whitehead","year":"2009","unstructured":"Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med. 2009;15(2):177\u201384. https:\/\/doi.org\/10.1038\/nm.1911.","journal-title":"Nat Med"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00619-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:06:48Z","timestamp":1791673608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00619-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":282,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00619-w","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests. The authors have no financial or personal relationships with other people or organizations that could inappropriately influence (bias) their work.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"202"}}